DOW INC., 10-Q filed on 4/25/2025
Quarterly Report
v3.25.1
Cover Page
 3 Months Ended
Mar. 31, 2025
$ / shares
shares
Document Information [Line Items]  
Document Type 10-Q
Document Quarterly Report true
Document Transition Report false
Entity Shell Company false
Entity Interactive Data Current Yes
Document Period End Date Mar. 31, 2025
Document Fiscal Year Focus 2025
Document Fiscal Period Focus Q1
Amendment Flag false
Entity Information [Line Items]  
Entity Registrant Name Dow Inc.
Entity Tax Identification Number 30-1128146
Entity File Number 001-38646
Entity Incorporation, State or Country Code DE
Entity Current Reporting Status Yes
Entity Shell Company false
Entity Filer Category Large Accelerated Filer
Entity Emerging Growth Company false
Entity Small Business false
Entity Central Index Key 0001751788
Current Fiscal Year End Date --12-31
Entity Addresses [Line Items]  
Entity Address, Address Line One 2211 H.H. Dow Way
Entity Address, City or Town Midland
Entity Address, State or Province MI
Entity Address, Postal Zip Code 48674
City Area Code 989
Local Phone Number 636-1000
Entity Listings [Line Items]  
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol DOW
Security Exchange Name NYSE
Entity Listing, Par Value Per Share | $ / shares $ 0.01
Entity Common Stock, Shares Outstanding | shares 706,861,738
The Dow Chemical Company  
Document Information [Line Items]  
Document Type 10-Q
Document Quarterly Report true
Document Transition Report false
Entity Shell Company false
Entity Interactive Data Current Yes
Document Period End Date Mar. 31, 2025
Document Fiscal Year Focus 2025
Document Fiscal Period Focus Q1
Amendment Flag false
Entity Information [Line Items]  
Entity Registrant Name The Dow Chemical Company
Entity Tax Identification Number 38-1285128
Entity File Number 001-03433
Entity Incorporation, State or Country Code DE
Entity Current Reporting Status Yes
Entity Shell Company false
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company false
Entity Small Business false
Entity Central Index Key 0000029915
Current Fiscal Year End Date --12-31
Entity Addresses [Line Items]  
Entity Address, Address Line One 2211 H.H. Dow Way
Entity Address, City or Town Midland
Entity Address, State or Province MI
Entity Address, Postal Zip Code 48674
City Area Code 989
Local Phone Number 636-1000
Entity Listings [Line Items]  
Entity Listing, Par Value Per Share | $ / shares $ 0.01
Entity Common Stock, Shares Outstanding | shares 100
The Dow Chemical Company | 0.500% Notes due March 15, 2027  
Entity Listings [Line Items]  
Title of 12(b) Security 0.500% Notes due March 15, 2027
Trading Symbol DOW/27
Security Exchange Name NYSE
The Dow Chemical Company | 1.125% Notes due March 15, 2032  
Entity Listings [Line Items]  
Title of 12(b) Security 1.125% Notes due March 15, 2032
Trading Symbol DOW/32
Security Exchange Name NYSE
The Dow Chemical Company | 1.875% Notes due March 15, 2040  
Entity Listings [Line Items]  
Title of 12(b) Security 1.875% Notes due March 15, 2040
Trading Symbol DOW/40
Security Exchange Name NYSE
The Dow Chemical Company | 4.625% Notes due October 1, 2044  
Entity Listings [Line Items]  
Title of 12(b) Security 4.625% Notes due October 1, 2044
Trading Symbol DOW/44
Security Exchange Name NYSE
v3.25.1
Dow Consolidated Statements of Income Statement - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Net sales $ 10,431 $ 10,765
Cost of sales 9,760 9,488
Research and development expenses 200 204
Selling, general and administrative expenses 366 442
Amortization of intangibles 76 81
Restructuring and asset related charges - net 208 45
Equity in earnings (losses) of nonconsolidated affiliates (20) 17
Sundry income (expense) - net 13 61
Interest income 28 65
Interest expense and amortization of debt discount 216 199
Income (loss) before income taxes (374) 449
Credit for income taxes (84) (89)
Net income (loss) (290) 538
Net income attributable to noncontrolling interests 17 22
Net income (loss) available for The Dow Chemical Company common stockholder $ (307) $ 516
Earnings (loss) per common share - basic $ (0.44) $ 0.73
Earnings (loss) per common share - diluted $ (0.44) $ 0.73
Weighted-average common shares outstanding - basic 706.9 704.5
Weighted-average common shares outstanding - diluted 706.9 705.5
v3.25.1
Dow Consolidated Statements of Comprehensive Income Statement - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Statement of Comprehensive Income [Abstract]    
Net income (loss) $ (290) $ 538
Other comprehensive income (loss), net of tax    
Unrealized gains (losses) on investments 32 (6)
Cumulative translation adjustments 122 (122)
Pension and other postretirement benefit plans 20 17
Derivative instruments (20) (22)
Total other comprehensive income (loss) 154 (133)
Comprehensive income (loss) (136) 405
Comprehensive income attributable to noncontrolling interests, net of tax 17 22
Comprehensive income (loss) attributable to Dow Inc. $ (153) $ 383
v3.25.1
Dow Consolidated Balance Sheets Statement - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Statement of Financial Position [Abstract]    
Cash and Cash Equivalents $ 1,465 $ 2,189
Trade (net of allowance for doubtful receivables - 2025: $78; 2024: $95) 4,917 4,756
Other 2,267 2,108
Inventories 6,765 6,544
Other current assets 914 993
Total current assets 16,328 16,590
Investment in nonconsolidated affiliates 1,275 1,266
Other investments (investments carried at fair value - 2025: $2,042; 2024: $2,047) 2,812 3,033
Noncurrent receivables 418 380
Total investments 4,505 4,679
Property 63,242 62,121
Less: Accumulated depreciation 40,912 40,117
Net property 22,330 22,004
Goodwill 8,619 8,565
Other intangible assets (net of accumulated amortization - 2025: $5,516; 2024: $5,394) 1,652 1,721
Operating lease right-of-use assets 1,320 1,268
Deferred income tax assets 1,460 1,257
Deferred charges and other assets 1,285 1,228
Total other assets 14,336 14,039
Total Assets 57,499 57,312
Notes payable 136 135
Long-term debt due within one year 502 497
Accounts payable - Trade 4,925 4,847
Accounts payable - Other 1,691 1,694
Operating lease liabilities - current 330 318
Income taxes payable 304 276
Accrued Liabilities, Current 2,698 2,521
Total current liabilities 10,586 10,288
Long-Term Debt 15,932 15,711
Deferred income tax liabilities 407 392
Pension and other postretirement benefits - noncurrent 4,700 4,736
Asbestos-related liabilities - noncurrent 688 713
Operating lease liabilities - noncurrent 1,021 984
Other noncurrent obligations 6,870 6,637
Total other noncurrent liabilities 13,686 13,462
Common stock (authorized 5,000,000,000 shares of $0.01 par value each; issued 2025: 785,933,796 shares; 2024: 784,471,939 shares) 8 8
Additional Paid in Capital, Common Stock 9,195 9,203
Retained earnings 20,101 20,909
Accumulated other comprehensive loss (7,956) (8,110)
Treasury stock at cost (2025: 79,072,058 shares; 2024: 80,859,145 shares) (4,560) (4,655)
Dow Inc.’s stockholders’ equity 16,788 17,355
Noncontrolling interests 507 496
Total equity 17,295 17,851
Total Liabilities and Equity $ 57,499 $ 57,312
v3.25.1
Dow Consolidated Balance Sheets Parentheticals - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Accounts Receivable, Allowance for Credit Loss, Current $ 78 $ 95
Investments, Fair Value Disclosure 2,042 2,047
Finite-Lived Intangible Assets, Accumulated Amortization $ 5,516 $ 5,394
Common Stock, Shares Authorized 5,000,000,000 5,000,000,000
Common Stock, Par or Stated Value Per Share $ 0.01 $ 0.01
Common Stock, Shares, Issued 785,933,796 784,471,939
Treasury Stock, Common, Shares 79,072,058 80,859,145
v3.25.1
Dow Consolidated Statements of Cash Flows Statement - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Statement of Cash Flows [Abstract]    
Net income (loss) $ (290) $ 538
Depreciation and amortization 714 720
Provision (credit) for deferred income tax (177) 7
Earnings of nonconsolidated affiliates less than dividends received 133 75
Net periodic pension benefit credit (26) (48)
Pension contributions (31) (34)
Net gain on sales of assets, businesses and investments (2) (11)
Restructuring and asset related charges - net 208 45
Other net loss 185 92
Accounts and notes receivable (301) (600)
Inventories (221) (297)
Accounts payable 38 398
Other assets and liabilities, net (126) (425)
Cash provided by operating activities - continuing operations 104 460
Cash provided by (used for) operating activities - discontinued operations (13) 4
Cash provided by operating activities 91 464
Capital expenditures (685) (714)
Investment in gas field developments (30) (52)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested 3 2
Investments in and loans to nonconsolidated affiliates (3) (2)
Purchases of investments (104) (679)
Proceeds from sales and maturities of investments 416 1,173
Other investing activities, net 2 1
Cash used for investing activities (401) (271)
Changes in short-term notes payable (1) (20)
Proceeds from issuance of short-term debt greater than three months 11 7
Payments on short-term debt greater than three months (6) 0
Proceeds from issuance of long-term debt 1,013 1,381
Payments on long-term debt (957) (93)
Collections on securitization programs 15 4
Purchases of treasury stock 0 (200)
Proceeds from issuance of stock 0 42
Transaction financing, debt issuance and other costs (64) (11)
Employee taxes paid for share-based payment arrangements (16) (37)
Distributions to noncontrolling interests (22) (14)
Dividends paid to stockholders (494) (493)
Cash provided by (used for) financing activities (521) 566
Effect of exchange rate changes on cash, cash equivalents and restricted cash 123 (54)
Increase (decrease) in cash, cash equivalents and restricted cash (708) 705
Cash, cash equivalents and restricted cash at beginning of period 2,263 3,048
Cash, cash equivalents and restricted cash at end of period 1,555 3,753
Less: Restricted cash and cash equivalents, included in "Other current assets" 90 30
Cash and cash equivalents and end of period $ 1,465 $ 3,723
v3.25.1
Dow Consolidated Statements of Equity Statement - USD ($)
$ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock, Common
Total equity   $ 8 $ 8,880 $ 21,774 $ (7,681) $ (4,374)
Stock Issued During Period, Value, Common Stock     42      
APIC, Share-based Payment Arrangement, Increase for Cost Recognition     87      
APIC, Stock Issued During Period, Value, Treasury Reissued - compensation and benefit plans     (67)      
Net Income (Loss) Available to Common Stockholders, Basic $ 513     516    
Dividends, Common Stock       (493)    
Transfer of Business Under Common Control       10    
Stockholders' Equity, Other       (11)    
Other Comprehensive Income (Loss), Net of Tax $ (133)       (133)  
Treasury Stock, Value, Acquired, Cost Method           (200)
Stock Issued During Period, Value Treasury Stock Reissued - compensation and benefit plans           67
Common Stock, Dividends, Per Share, Declared $ 0.70          
Dow Inc.’s stockholders’ equity $ 18,425          
Noncontrolling interests 492          
Total equity 18,917 8 8,942 21,796 (7,814) (4,507)
Dow Inc.’s stockholders’ equity 17,355          
Noncontrolling interests 496          
Total equity 17,851 8 9,203 20,909 (8,110) (4,655)
Stock Issued During Period, Value, Common Stock     0      
APIC, Share-based Payment Arrangement, Increase for Cost Recognition     87      
APIC, Stock Issued During Period, Value, Treasury Reissued - compensation and benefit plans     (95)      
Net Income (Loss) Available to Common Stockholders, Basic (310)     (307)    
Dividends, Common Stock       (494)    
Transfer of Business Under Common Control       0    
Stockholders' Equity, Other       (7)    
Other Comprehensive Income (Loss), Net of Tax $ 154       154  
Treasury Stock, Value, Acquired, Cost Method           0
Stock Issued During Period, Value Treasury Stock Reissued - compensation and benefit plans           95
Common Stock, Dividends, Per Share, Declared $ 0.70          
Dow Inc.’s stockholders’ equity $ 16,788          
Noncontrolling interests 507          
Total equity $ 17,295 $ 8 $ 9,195 $ 20,101 $ (7,956) $ (4,560)
v3.25.1
Consolidated Statements of Income - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Net sales $ 10,431 $ 10,765
Cost of sales 9,760 9,488
Research and development expenses 200 204
Selling, general and administrative expenses 366 442
Amortization of intangibles 76 81
Restructuring and asset related charges - net 208 45
Equity in earnings (losses) of nonconsolidated affiliates (20) 17
Sundry income (expense) - net 13 61
Interest income 28 65
Interest expense and amortization of debt discount 216 199
Income (loss) before income taxes (374) 449
Credit for income taxes (84) (89)
Net income (loss) (290) 538
Net income attributable to noncontrolling interests 17 22
Net income (loss) available for The Dow Chemical Company common stockholder (307) 516
The Dow Chemical Company    
Net sales 10,431 10,765
Cost of sales 9,759 9,487
Research and development expenses 200 204
Selling, general and administrative expenses 366 442
Amortization of intangibles 76 81
Restructuring and asset related charges - net 208 45
Equity in earnings (losses) of nonconsolidated affiliates (20) 17
Sundry income (expense) - net 13 61
Interest income 29 69
Interest expense and amortization of debt discount 216 199
Income (loss) before income taxes (372) 454
Credit for income taxes (84) (89)
Net income (loss) (288) 543
Net income attributable to noncontrolling interests 17 22
Net income (loss) available for The Dow Chemical Company common stockholder $ (305) $ 521
v3.25.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Net income (loss) $ (290) $ 538
Other comprehensive income (loss), net of tax    
Unrealized gains (losses) on investments 32 (6)
Cumulative translation adjustments 122 (122)
Pension and other postretirement benefit plans 20 17
Derivative instruments (20) (22)
Other Comprehensive Income (Loss), Net of Tax 154 (133)
Comprehensive Income (136) 405
Comprehensive income attributable to noncontrolling interests, net of tax 17 22
Comprehensive income (loss) attributable to Dow Inc. (153) 383
The Dow Chemical Company    
Net income (loss) (288) 543
Other comprehensive income (loss), net of tax    
Unrealized gains (losses) on investments 32 (6)
Cumulative translation adjustments 122 (122)
Pension and other postretirement benefit plans 20 17
Derivative instruments (20) (22)
Other Comprehensive Income (Loss), Net of Tax 154 (133)
Comprehensive Income (134) 410
Comprehensive income attributable to noncontrolling interests, net of tax 17 22
Comprehensive income (loss) attributable to Dow Inc. $ (151) $ 388
v3.25.1
TDCC Consolidated Balance Sheets (Statement) - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Cash and Cash Equivalents $ 1,465 $ 2,189
Trade (net of allowance for doubtful receivables - 2025: $78; 2024: $95) 4,917 4,756
Other 2,267 2,108
Inventories 6,765 6,544
Other current assets 914 993
Total current assets 16,328 16,590
Investment in nonconsolidated affiliates 1,275 1,266
Other investments (investments carried at fair value - 2025: $2,042; 2024: $2,047) 2,812 3,033
Noncurrent receivables 418 380
Total investments 4,505 4,679
Property 63,242 62,121
Less: Accumulated depreciation 40,912 40,117
Net property 22,330 22,004
Goodwill 8,619 8,565
Other intangible assets (net of accumulated amortization - 2025: $5,516; 2024: $5,394) 1,652 1,721
Operating lease right-of-use assets 1,320 1,268
Deferred income tax assets 1,460 1,257
Deferred charges and other assets 1,285 1,228
Total other assets 14,336 14,039
Total Assets 57,499 57,312
Notes payable 136 135
Long-term debt due within one year 502 497
Accounts payable - Trade 4,925 4,847
Accounts payable - Other 1,691 1,694
Operating lease liabilities - current 330 318
Income taxes payable 304 276
Accrued Liabilities, Current 2,698 2,521
Total current liabilities 10,586 10,288
Long-Term Debt 15,932 15,711
Deferred income tax liabilities 407 392
Pension and other postretirement benefits - noncurrent 4,700 4,736
Asbestos-related liabilities - noncurrent 688 713
Operating lease liabilities - noncurrent 1,021 984
Other noncurrent obligations 6,870 6,637
Total other noncurrent liabilities 13,686 13,462
Common stock (authorized and issued 100 shares of $0.01 par value each) 8 8
Additional Paid in Capital, Common Stock 9,195 9,203
Retained earnings 20,101 20,909
Accumulated other comprehensive loss (7,956) (8,110)
Dow Inc.’s stockholders’ equity 16,788 17,355
Noncontrolling interests 507 496
Total equity 17,295 17,851
Total Liabilities and Equity 57,499 57,312
The Dow Chemical Company    
Cash and Cash Equivalents 1,465 2,189
Trade (net of allowance for doubtful receivables - 2025: $78; 2024: $95) 4,917 4,756
Other 2,270 2,116
Inventories 6,765 6,544
Other current assets 858 960
Total current assets 16,275 16,565
Investment in nonconsolidated affiliates 1,275 1,266
Other investments (investments carried at fair value - 2025: $2,042; 2024: $2,047) 2,812 3,033
Noncurrent receivables 412 374
Total investments 4,499 4,673
Property 63,242 62,121
Less: Accumulated depreciation 40,912 40,117
Net property 22,330 22,004
Goodwill 8,619 8,565
Other intangible assets (net of accumulated amortization - 2025: $5,516; 2024: $5,394) 1,652 1,721
Operating lease right-of-use assets 1,320 1,268
Deferred income tax assets 1,460 1,257
Deferred charges and other assets 1,285 1,228
Total other assets 14,336 14,039
Total Assets 57,440 57,281
Notes payable 136 135
Long-term debt due within one year 502 497
Accounts payable - Trade 4,925 4,847
Accounts payable - Other 1,708 1,732
Operating lease liabilities - current 330 318
Income taxes payable 304 276
Accrued Liabilities, Current 2,597 2,405
Total current liabilities 10,502 10,210
Long-Term Debt 15,932 15,711
Deferred income tax liabilities 407 392
Pension and other postretirement benefits - noncurrent 4,700 4,736
Asbestos-related liabilities - noncurrent 688 713
Operating lease liabilities - noncurrent 1,021 984
Other noncurrent obligations 6,733 6,503
Total other noncurrent liabilities 13,549 13,328
Common stock (authorized and issued 100 shares of $0.01 par value each) 0 0
Additional Paid in Capital, Common Stock 9,713 9,626
Retained earnings 15,193 16,020
Accumulated other comprehensive loss (7,956) (8,110)
Dow Inc.’s stockholders’ equity 16,950 17,536
Noncontrolling interests 507 496
Total equity 17,457 18,032
Total Liabilities and Equity $ 57,440 $ 57,281
v3.25.1
TDCC Consolidated Statements of Cash Flows Statement - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Net income (loss) $ (290) $ 538
Depreciation and amortization 714 720
Provision (credit) for deferred income tax (177) 7
Earnings of nonconsolidated affiliates less than dividends received 133 75
Net periodic pension benefit credit (26) (48)
Pension contributions (31) (34)
Net gain on sales of assets, businesses and investments (2) (11)
Restructuring and asset related charges - net 208 45
Other net loss 185 92
Accounts and notes receivable (301) (600)
Inventories (221) (297)
Accounts payable 38 398
Other assets and liabilities, net (126) (425)
Cash provided by operating activities 91 464
Capital expenditures (685) (714)
Investment in gas field developments (30) (52)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested 3 2
Investments in and loans to nonconsolidated affiliates (3) (2)
Purchases of investments (104) (679)
Proceeds from sales and maturities of investments 416 1,173
Other investing activities, net 2 1
Cash used for investing activities (401) (271)
Changes in short-term notes payable (1) (20)
Proceeds from issuance of short-term debt greater than three months 11 7
Payments on short-term debt greater than three months (6) 0
Proceeds from issuance of long-term debt 1,013 1,381
Payments on long-term debt (957) (93)
Collections on securitization programs 15 4
Proceeds from issuance of stock 0 42
Transaction financing, debt issuance and other costs (64) (11)
Employee taxes paid for share-based payment arrangements (16) (37)
Distributions to noncontrolling interests (22) (14)
Dividends paid to stockholders (494) (493)
Cash provided by (used for) financing activities (521) 566
Effect of exchange rate changes on cash, cash equivalents and restricted cash 123 (54)
Increase (decrease) in cash, cash equivalents and restricted cash (708) 705
Cash, cash equivalents and restricted cash at beginning of period 2,263 3,048
Cash, cash equivalents and restricted cash at end of period 1,555 3,753
Less: Restricted cash and cash equivalents, included in "Other current assets" 90 30
Cash and cash equivalents and end of period 1,465 3,723
The Dow Chemical Company    
Net income (loss) (288) 543
Depreciation and amortization 714 720
Provision (credit) for deferred income tax (177) 7
Earnings of nonconsolidated affiliates less than dividends received 133 75
Net periodic pension benefit credit (26) (48)
Pension contributions (31) (34)
Net gain on sales of assets, businesses and investments (2) (11)
Restructuring and asset related charges - net 208 45
Other net loss 185 92
Accounts and notes receivable (301) (600)
Inventories (221) (297)
Accounts payable 38 398
Other assets and liabilities, net (120) (421)
Cash provided by operating activities 112 469
Capital expenditures (685) (714)
Investment in gas field developments (30) (52)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested 3 2
Investments in and loans to nonconsolidated affiliates (3) (2)
Purchases of investments (104) (679)
Proceeds from sales and maturities of investments 416 1,173
Other investing activities, net 2 1
Cash used for investing activities (401) (271)
Changes in short-term notes payable (1) (20)
Proceeds from issuance of short-term debt greater than three months 11 7
Payments on short-term debt greater than three months (6) 0
Proceeds from issuance of long-term debt 1,013 1,381
Payments on long-term debt (957) (93)
Collections on securitization programs 15 4
Proceeds from issuance of stock 0 42
Transaction financing, debt issuance and other costs (64) (11)
Employee taxes paid for share-based payment arrangements (16) (37)
Distributions to noncontrolling interests (22) (14)
Dividends paid to stockholders (515) (698)
Cash provided by (used for) financing activities (542) 561
Effect of exchange rate changes on cash, cash equivalents and restricted cash 123 (54)
Increase (decrease) in cash, cash equivalents and restricted cash (708) 705
Cash, cash equivalents and restricted cash at beginning of period 2,263 3,048
Cash, cash equivalents and restricted cash at end of period 1,555 3,753
Less: Restricted cash and cash equivalents, included in "Other current assets" 90 30
Cash and cash equivalents and end of period $ 1,465 $ 3,723
v3.25.1
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Dow Inc. [Member]
Retained Earnings [Member]
The Dow Chemical Company
The Dow Chemical Company
Common Stock [Member]
The Dow Chemical Company
Additional Paid-in Capital [Member]
The Dow Chemical Company
Retained Earnings [Member]
The Dow Chemical Company
Accumulated Other Comprehensive Loss
The Dow Chemical Company
Noncontrolling Interests
Total Equity, Beginning at Dec. 31, 2023   $ 8 $ 8,880 $ 21,774 $ (7,681) $ 501     $ 0 $ 9,091 $ 17,495 $ (7,681)  
Stock Issued                   42      
Stock-based compensation and allocation of ESOP shares     87             87      
Net income available for The Dow Chemical Company common stockholder $ 513     516             521    
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             $ (791)            
Other       11             (11)    
Other comprehensive income (133)       (133)     $ (133)       (133)  
Total Equity, Ending at Mar. 31, 2024 18,917 8 8,942 21,796 (7,814) 492   19,112 0 9,220 17,214 (7,814) $ 492
The Dow Chemical Company’s stockholders’ equity 18,425             18,620          
The Dow Chemical Company’s stockholders’ equity 17,355             17,536          
Total Equity, Beginning at Dec. 31, 2024 17,851 8 9,203 20,909 (8,110) 496   18,032 0 9,626 16,020 (8,110)  
Stock Issued                   0      
Stock-based compensation and allocation of ESOP shares     87             87      
Net income available for The Dow Chemical Company common stockholder (310)     (307)             (305)    
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees             $ (515)            
Other       7             (7)    
Other comprehensive income 154       154     154       154  
Total Equity, Ending at Mar. 31, 2025 17,295 $ 8 $ 9,195 $ 20,101 $ (7,956) $ 507   17,457 $ 0 $ 9,713 $ 15,193 $ (7,956) $ 507
The Dow Chemical Company’s stockholders’ equity $ 16,788             $ 16,950          
v3.25.1
Dow Consolidated Statements of Income - Supplemental Info - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Supplemental Income Statement Elements [Abstract]    
Depreciation $ 512 $ 481
Capital expenditures $ 685 $ 714
v3.25.1
TDCC Consolidated Statements of Income - Supplemental Info - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Depreciation $ 512 $ 481
Capital expenditures 685 714
The Dow Chemical Company    
Depreciation 512 481
Capital expenditures $ 685 $ 714
v3.25.1
TDCC Consolidated Balance Sheets Parentheticals - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Accounts Receivable, Allowance for Credit Loss, Current $ 78 $ 95
Investments, Fair Value Disclosure 2,042 2,047
Finite-Lived Intangible Assets, Accumulated Amortization $ 5,516 $ 5,394
Common Stock, Shares, Issued 785,933,796 784,471,939
Common Stock, Shares Authorized 5,000,000,000 5,000,000,000
Common Stock, Par or Stated Value Per Share $ 0.01 $ 0.01
The Dow Chemical Company    
Accounts Receivable, Allowance for Credit Loss, Current $ 78 $ 95
Finite-Lived Intangible Assets, Accumulated Amortization $ 5,516 $ 5,394
Common Stock, Shares, Issued 100 100
Common Stock, Shares Authorized 100 100
Common Stock, Par or Stated Value Per Share $ 0.01 $ 0.01
v3.25.1
CONSOLIDATED FINANCIAL STATEMENTS (Notes)
 3 Months Ended
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
CONSOLIDATED FINANCIAL STATEMENTS CONSOLIDATED FINANCIAL STATEMENTS
Basis of Presentation
Dow Inc. is the direct parent company of The Dow Chemical Company and its consolidated subsidiaries ("TDCC" and together with Dow Inc., "Dow" or the "Company"). The unaudited interim consolidated financial statements of Dow Inc. and TDCC were prepared in accordance with accounting principles generally accepted in the United States of America and reflect all adjustments (including normal recurring accruals) which, in the opinion of management, are considered necessary for the fair presentation of the results for the periods presented. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2024 ("2024 10-K").

As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and considering that the financial statements and disclosures of each company are substantially similar, the companies are filing a combined report for this Quarterly Report on Form 10-Q. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Transactions between TDCC and Dow Inc. are treated as related party transactions for TDCC.

Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation and the term "Dow Silicones" means Dow Silicones Corporation, both wholly owned subsidiaries of the Company.
v3.25.1
RECENT ACCOUNTING GUIDANCE (Notes)
 3 Months Ended
Mar. 31, 2025
Accounting Changes and Error Corrections [Abstract]  
RECENT ACCOUNTING GUIDANCE RECENT ACCOUNTING GUIDANCE
Recently Adopted Accounting Guidance
In the fourth quarter of 2024, the Company adopted the annual and interim disclosure requirements of Accounting Standards Update ("ASU") 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures." The amendments expand a public business entity's segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), clarifying when an entity may report one or more additional measures to assess segment performance, requiring enhanced interim disclosures, providing new disclosure requirements for entities with a single reportable segment, and requiring other new disclosures. See Note 18 for applicable reportable segment disclosures required by this guidance.

Accounting Guidance Issued But Not Adopted at March 31, 2025
In December 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures," which is intended to enhance the transparency, decision usefulness and effectiveness of income tax disclosures. The amendments in this ASU require a public business entity to disclose a tabular tax rate reconciliation, using both percentages and currency, with specific categories. A public business entity is also required to provide a qualitative description of the states and local jurisdictions that make up the majority of the effect of the state and local income tax category and the net amount of income taxes paid, disaggregated by federal, state and foreign taxes and also disaggregated by individual jurisdictions. The amendments also remove certain disclosures that are no longer considered cost beneficial. The amendments are effective prospectively for annual periods beginning after December 15, 2024, and early adoption and retrospective application are permitted. The adoption of the ASU is not expected to have a material impact on the Company's consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses," which is intended to improve disclosures about a public business entity's expenses and address requests from investors for more detailed information about the types of expenses in commonly presented expense captions. Such information should allow investors to better understand an entity's performance, assess future cash flows, and compare performance over time and with other entities. The amendments will require public business entities to disclose in the notes to the financial statements, at each interim and annual reporting period, specific information about certain costs and expenses, including purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each expense caption presented on the face of the income statement, and the total amount of an entity's selling expenses. The amendments are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, and may be applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of adopting this guidance on the consolidated financial statements.

SEC Final Rules Not Adopted at March 31, 2025
In March 2024, the U.S. Securities and Exchange Commission ("SEC") adopted final rules under SEC Release Nos. 33-11275 and 34-99678, "The Enhancement and Standardization of Climate-Related Disclosures for Investors," which requires registrants to disclose certain climate-related information in registration statements and annual reports. As a large accelerated filer, most disclosure requirements would be effective for the Company beginning in the year ending December 31, 2025, with certain greenhouse gas emissions disclosures required for the year ending December 31, 2026. In April 2024, the SEC issued an order to stay the final rules until various legal challenges are resolved by the U.S. Court of Appeals for the Eighth Circuit ("Court of Appeals"). In March 2025, the SEC voted to end its defense of the final rules; however, the Court of Appeals may still rule on the matter.
v3.25.1
REVENUE (Notes)
 3 Months Ended
Mar. 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenue from Contract with Customer [Text Block] REVENUE
Revenue Recognition
The majority of the Company's revenue is derived from product sales. The Company's revenue related to product sales was 97 percent for the three months ended March 31, 2025 (98 percent for the three months ended March 31, 2024). The remaining sales were primarily related to the Company's insurance operations and licensing of patents and technologies. Product sales consist of sales of the Company's products to manufacturers and distributors. The Company considers order confirmations or purchase orders, which in some cases are governed by master supply agreements, to be contracts with a customer. The Company enters into licensing arrangements in which it licenses certain rights of its patents and technology to customers. Revenue from the Company’s licenses for patents and
technology is derived from sales-based royalties and licensing arrangements based on billing schedules established in each contract.

Remaining Performance Obligations
Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. At March 31, 2025, the Company had unfulfilled performance obligations of $769 million ($759 million at December 31, 2024) related to the licensing of technology. The Company expects revenue to be recognized for the remaining performance obligations over the next six years.

The Company has additional remaining performance obligations for product sales that have expected durations of one year or less, product sales of materials delivered through a pipeline for which the Company has elected the "right to invoice" practical expedient, and variable consideration attributable to royalties for licenses of patents and technology. The Company has received advance payments from customers related to long-term supply agreements that are deferred and recognized over the life of the contract, with remaining contract terms that range up to 19 years. The Company will have rights to future consideration for revenue recognized when product is delivered to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.

Disaggregation of Revenue
The Company disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See details in the tables below:

Net Trade Sales by Segment and BusinessThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Hydrocarbons & Energy$1,578 $1,467 
Packaging and Specialty Plastics3,732 3,963 
Packaging & Specialty Plastics$5,310 $5,430 
Industrial Solutions $1,054 $1,028 
Polyurethanes & Construction Chemicals1,797 1,977 
Other4 3 
Industrial Intermediates & Infrastructure$2,855 $3,008 
Coatings & Performance Monomers$845 $885 
Consumer Solutions1,226 1,267 
Performance Materials & Coatings$2,071 $2,152 
Corporate$195 $175 
Total$10,431 $10,765 

Net Trade Sales by Geographic RegionThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
U.S. & Canada$4,227 $4,130 
EMEAI 1
3,274 3,484 
Asia Pacific1,858 1,921 
Latin America1,072 1,230 
Total$10,431 $10,765 
1.Europe, Middle East, Africa and India.

Contract Assets and Liabilities
The Company receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company's contractual right to consideration for completed performance obligations not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are recognized in revenue
when the performance obligations are met. "Contract liabilities - current" primarily reflects deferred revenue from prepayments from customers for product to be delivered in 12 months or less and royalty payments that are deferred and will be recognized in 12 months or less. "Contract liabilities - noncurrent" includes advance payments that the Company has received from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract.

Revenue recognized in the first three months of 2025 from amounts included in contract liabilities at the beginning of the period was approximately $80 million (approximately $40 million in the first three months of 2024). In the first three months of 2025, the amount of contract assets reclassified to receivables as a result of the right to the transaction consideration becoming unconditional was insignificant (no contract assets reclassified to receivables in the first three months of 2024).

The following table summarizes contract assets and liabilities at March 31, 2025 and December 31, 2024:

Contract Assets and LiabilitiesBalance Sheet ClassificationMar 31, 2025Dec 31, 2024
In millions
Accounts and notes receivable - tradeAccounts and notes receivable - trade$4,917 $4,756 
Contract assets - noncurrentDeferred charges and other assets$— $2 
Contract liabilities - currentAccrued and other current liabilities$207 $244 
Contract liabilities - noncurrent Other noncurrent obligations$1,459 $1,480 
v3.25.1
RESTRUCTURING AND ASSET RELATED CHARGES - NET (Notes)
 3 Months Ended
Mar. 31, 2025
Restructuring and Related Activities [Abstract]  
Restructuring and Related Activities Disclosure [Text Block] RESTRUCTURING AND ASSET RELATED CHARGES - NET
Charges for restructuring programs and other asset related charges, which include asset impairments, are recorded in "Restructuring and asset related charges - net" in the consolidated statements of income. For additional information on the Company's restructuring programs, see Note 5 to the Consolidated Financial Statements included in the 2024 10-K.

2025 Restructuring Program
On January 27, 2025, the Dow Inc. Board of Directors ("Board") approved targeted actions to further achieve the Company's cost reduction initiatives in response to ongoing macroeconomic uncertainty, while reinforcing its long-term competitiveness across the economic cycle. The actions include a workforce reduction of approximately 1,500 roles. As a result of these actions, in the first quarter of 2025 the Company recorded pretax charges of $207 million for severance and related benefits costs, included in "Restructuring and asset related charges - net" in the consolidated statements of income, related to Corporate. Costs to implement the targeted actions are expected to result in additional cash expenditures of approximately $10 million. These actions are expected to be substantially complete by the end of 2026. At March 31, 2025, $167 million of the restructuring reserve balance was included in "Accrued and other current liabilities" and $40 million was included in "Other noncurrent obligations" in the consolidated balance sheets.

2023 Restructuring Program
Actions related to the restructuring program approved by the Board on January 25, 2023, were substantially complete at the end of the first quarter of 2025, with the exception of certain cash payments that will continue primarily through the second quarter of 2025. In the first quarter of 2025, the Company recorded an additional pretax restructuring charge of $5 million for asset write-downs and write-offs and an asset related credit adjustment of $4 million, included in "Restructuring and asset related charges - net" in the consolidated statements of income, related to Industrial Intermediates & Infrastructure. See Note 17 for additional information on nonrecurring fair value measurements. Restructuring implementation and efficiency costs totaled $50 million for the three months ended March 31, 2025 ($46 million for the three months ended March 31, 2024).

Subsequent Event
On April 24, 2025, the Company announced actions to further address the impact on the Company from ongoing macroeconomic volatility and slower GDP growth. The actions include the expansion of the previously announced strategic review of select European assets, which is focused on addressing the persistently challenging demand dynamics and regulatory environment in the geographic region. The Company expects to complete the review of its European assets and announce final actions by mid-2025, and has initially identified three assets it believes will require further action. The assets identified represent higher-cost, energy intensive upstream portions of the
Company’s portfolio, and include an ethylene facility in Böhlen, Germany (Packaging & Specialty Plastics), chlor-alkali and vinyl assets in Schkopau, Germany (Industrial Intermediates & Infrastructure), and a basics siloxanes plant in Barry, United Kingdom (Performance Materials & Coatings). The assets will be evaluated for potential idle or shut down. The assets have a total net book value of approximately $275 million and the Company will assess the potential impact of the actions on the assets’ carrying values as the review progresses.
v3.25.1
SUPPLEMENTARY INFORMATION (Notes)
 3 Months Ended
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplementary Information Disclosure [Text Block] SUPPLEMENTARY INFORMATION
Dow Inc. Sundry Income (Expense) – NetThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Non-operating pension and other postretirement benefit plan net credits 1
$38 $61 
Foreign exchange gains (losses) 2
7 (23)
Gain (loss) on sales of other assets and investments(3)9 
Loss on early extinguishment of debt 3
(60)— 
Other - net31 14 
Total sundry income (expense) – net$13 $61 
1.See Note 14 for additional information.
2.Foreign exchange losses for the three months ended March 31, 2024 relate primarily to exposures in the Egyptian pound and Argentine peso.
3.See Note 9 for additional information.

Sundry income (expense) - net for TDCC for the three months ended March 31, 2025 and 2024 is substantially the same as that of Dow Inc. and, therefore, Sundry income (expense) - net for TDCC is not disclosed separately.

Other Investments
The Company has investments in company-owned life insurance policies, which are recorded at their cash surrender value as of each balance sheet date, as provided below:

Investments in Company-Owned Life InsuranceMar 31, 2025Dec 31, 2024
In millions
Gross cash value$544 $558 
Less: Existing drawdowns 1
200 — 
Investments in company-owned life insurance 2
$344 $558 
1.Classified as "Proceeds from sales and maturities of investments" in the consolidated statements of cash flows.
2.Classified as "Other investments" in the consolidated balance sheets.

Supplier Finance Program
The Company facilitates a supply chain financing (“SCF”) program in the ordinary course of business in order to extend payment terms with vendors. Under the terms of this program, a vendor can voluntarily enter into an agreement with a participating financial intermediary to sell its receivables due from the Company. The vendor receives payment from the financial intermediary, and the Company pays the financial intermediary on the terms originally negotiated with the vendor, which generally range from 90 to 120 days. The vendor negotiates the terms of the agreements directly with the financial intermediary and the Company is not a party to that agreement. The financial intermediary may allow the participating vendor to utilize the Company’s creditworthiness in establishing credit spreads and associated costs, which may provide the vendor with more favorable terms than they would be able to secure on their own. The Company does not provide guarantees related to the SCF program. At March 31, 2025, outstanding obligations confirmed as valid under the SCF program were $285 million ($291 million at December 31, 2024), included in “Accounts payable – Trade” in the consolidated balance sheets.
v3.25.1
EARNINGS PER SHARE (Notes)
 3 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block] EARNINGS PER SHARE CALCULATIONS
The following tables provide earnings per share calculations for Dow Inc. for the three months ended March 31, 2025 and 2024. Earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries.

Net Income (Loss) for Earnings Per Share CalculationsThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Net income (loss)$(290)$538 
Net income attributable to noncontrolling interests17 22 
Net income attributable to participating securities 1
3 3 
Net income (loss) attributable to common stockholders$(310)$513 
1.Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares.

Earnings (Loss) Per Share - Basic and DilutedThree Months Ended
Dollars per shareMar 31, 2025Mar 31, 2024
Earnings (loss) per common share - basic$(0.44)$0.73 
Earnings (loss) per common share - diluted$(0.44)$0.73 

Share Count InformationThree Months Ended
Shares in millionsMar 31, 2025Mar 31, 2024
Weighted-average common shares outstanding - basic706.9 704.5 
Plus dilutive effect of equity compensation plans 1
— 1.0 
Weighted-average common shares outstanding - diluted706.9 705.5 
Stock units excluded from EPS calculations 2
14.9 8.8 
1.The three months ended March 31, 2025 reflect a net loss and, as such, the basic share count was used for purposes of calculating earnings per share on a diluted basis.
2.These outstanding stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.
v3.25.1
INVENTORIES (Notes)
 3 Months Ended
Mar. 31, 2025
Inventory Disclosure [Abstract]  
INVENTORIES INVENTORIES
The following table provides a breakdown of inventories:

InventoriesMar 31, 2025Dec 31, 2024
In millions
Finished goods$3,947 $3,773 
Work in process1,368 1,323 
Raw materials847 822 
Supplies1,084 1,039 
Total$7,246 $6,957 
Adjustment of inventories to the LIFO basis(481)(413)
Total inventories$6,765 $6,544 
v3.25.1
TRANSFERS OF FINANCIAL ASSETS
 3 Months Ended
Mar. 31, 2025
Transfers and Servicing [Abstract]  
TRANSFERS OF FINANCIAL ASSETS TRANSFERS OF FINANCIAL ASSETS
Accounts Receivable Programs
The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States and a committed facility in Europe (collectively, "the Programs"), which are set to expire in November 2025. Under the terms of the Programs, the Company may sell certain eligible trade accounts receivable at any point in time, up to $900 million for the U.S. committed facility and up to €500 million for the Europe committed facility. Under the terms of the Programs, the Company continues to service the receivables from the customer, but retains no interest in the receivables, and remits payment to the financial institutions. Losses on transfers of receivables were insignificant for the three months ended March 31, 2025 and 2024. The Company also provides a guarantee to the financial institutions for the creditworthiness and collection of the receivables in satisfaction of the facility. See Note 10 for additional information related to guarantees.

The Company has access to accounts receivable discounting facilities that cover certain receivables generated from sales in EMEAI, Asia Pacific and Canada (collectively, "the Facilities"). Under the terms of the Facilities, the Company retains no interest in the transferred receivables once sold and receivables are transferred with limited recourse. The Company continues to service the receivables from the customer and remits payment to the Facilities. Losses on transfers of receivables were insignificant for the three months ended March 31, 2025 and 2024.

The following table provides a summary of cash flows related to the Programs and the Facilities for the three months ended March 31, 2025 and 2024:

Cash Flows Related to Transfers of Accounts ReceivableThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Proceeds received from new transfers$514 $427 

The following table provides the balances related to the Programs and the Facilities at March 31, 2025 and December 31, 2024:

Balances Related to Transfers of Accounts ReceivableMar 31, 2025Dec 31, 2024
In millions
Balance outstanding$535$287
Accounts receivable derecognized $511$278
Amounts recognized in the consolidated balance sheets:
    Accrued and other current liabilities 1
$24$9
1. Represents amounts collected from customers and not yet remitted by the Company.
v3.25.1
NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Notes)
 3 Months Ended
Mar. 31, 2025
Debt Disclosure [Abstract]  
Debt Disclosure NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES
Notes PayableMar 31, 2025Dec 31, 2024
In millions
Notes payable to banks and other lenders$136$135
Period-end average interest rates28.93 %36.03 %

Long-Term Debt
2025 Average Rate
Mar 31, 2025
2024 Average Rate
Dec 31, 2024
In millions
Promissory notes and debentures:
Final maturity 20255.63 %$333 5.63 %$333 
Final maturity 20284.80 %600 4.80 %600 
Final maturity 2029 1
7.53 %951 7.58 %1,368 
Final maturity 20302.10 %818 2.10 %818 
Final maturity 2031 and thereafter 1
5.41 %10,209 5.37 %9,192 
Other facilities:
Foreign currency notes and loans, various rates and maturities 1
2.18 %2,094 2.01 %2,540 
InterNotes®, varying maturities through 20534.34 %668 4.31 %661 
Medium-term notes, maturity 20254.75 %1 4.75 %1 
Finance lease obligations 2
985 939 
Unamortized debt discount and issuance costs(225)(244)
Long-term debt due within one year 3
(502)(497)
Long-term debt$15,932 $15,711 
1.Cost includes net fair value hedge adjustment gains of $29 million at March 31, 2025 ($9 million at December 31, 2024). See Note 16 for additional information.
2.See Note 11 for additional information.
3.Presented net of current portion of unamortized debt issuance costs.

Maturities of Long-Term Debt for Next Five Years at Mar 31, 2025
In millions
2025$472 
2026$149 
2027$746 
2028$702 
2029$1,045 
2030$911 

2025 Activity
In the first quarter of 2025, the Company issued $1 billion of senior unsecured notes. The offering included $400 million aggregate principal amount of 5.35 percent notes due 2035 and $600 million aggregate principal amount of 5.95 percent notes due 2055. The Company used the proceeds to complete cash tender offers for certain debt securities. In total, $943 million aggregate principal amount was tendered and retired. As a result, the Company recognized a pretax loss of $60 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income, related to Corporate.

In the first quarter of 2025, the Company issued an aggregate principal amount of $13 million of InterNotes®.
Available Credit Facilities
The following table summarizes the Company's credit facilities:

Committed and Available Credit Facilities at Mar 31, 2025
In millionsCommitted CreditAvailable CreditMaturity DateInterest
Five Year Competitive Advance and Revolving Credit Facility$5,000 $5,000 November 2028Floating rate
Bilateral Revolving Credit Facility200 200 September 2025Floating rate
Bilateral Revolving Credit Facility175 175 September 2025Floating rate
Bilateral Revolving Credit Facility300 300 November 2025Floating rate
Bilateral Revolving Credit Facility300 300 February 2026Floating rate
Bilateral Revolving Credit Facility100 100 March 2026Floating rate
Bilateral Revolving Credit Facility375 375 October 2026Floating rate
Bilateral Revolving Credit Facility150 150 November 2026Floating rate
Bilateral Revolving Credit Facility200 200 November 2026Floating rate
Bilateral Revolving Credit Facility250 250 March 2027Floating rate
Bilateral Revolving Credit Facility100 100 May 2027Floating rate
Bilateral Revolving Credit Facility350 350 June 2027Floating rate
Bilateral Revolving Credit Facility200 200 September 2027Floating rate
Bilateral Revolving Credit Facility100 100 October 2027Floating rate
Bilateral Revolving Credit Facility100 100 November 2027Floating rate
Bilateral Revolving Credit Facility100 100 March 2028Floating rate
Bilateral Revolving Credit Facility100 100 March 2028Floating rate
Bilateral Revolving Credit Facility300 300 May 2028Floating rate
Total committed and available credit facilities$8,400 $8,400 

Debt Covenants and Default Provisions
There were no material changes to the debt covenants and default provisions related to the Company's outstanding long-term debt and primary, private credit agreements in the first three months of 2025. For additional information on the Company's debt covenants and default provisions, see Note 14 to the Consolidated Financial Statements included in the 2024 10-K.
v3.25.1
COMMITMENTS AND CONTINGENCIES (Notes)
 3 Months Ended
Mar. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure COMMITMENTS AND CONTINGENCIES
A summary of the Company's commitments and contingencies can be found in Note 15 to the Consolidated Financial Statements included in the 2024 10-K, which is incorporated by reference herein.

Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. At March 31, 2025, the Company had accrued obligations of $1,072 million for probable environmental remediation and restoration costs ($1,113 million at December 31, 2024), including $227 million for the remediation of Superfund sites ($234 million at December 31, 2024). This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately two times that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company's results of operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. As new or additional information becomes available and/or certain spending trends become known, management will evaluate such information in determination of the current estimate of environmental liability.

Litigation
Asbestos-Related Matters of Union Carbide Corporation
Each quarter, Union Carbide reviews asbestos-related claims filed, settled and dismissed, as well as average settlement and resolution costs by disease category. Union Carbide also considers additional quantitative and qualitative factors such as the nature of pending claims, trial experience of Union Carbide and other asbestos defendants, current spending for defense and processing costs, significant appellate rulings and legislative developments, trends in the tort system, and their respective effects on expected future resolution costs. Union Carbide's management considers these factors in conjunction with the most recent actuarial study and determines whether a change in the estimate is warranted. Based on Union Carbide's review of 2025 activity, it was determined that no adjustment to the accrual was required at March 31, 2025.

Union Carbide’s total asbestos-related liability for pending and future claims and defense and processing costs was $767 million at March 31, 2025 ($791 million at December 31, 2024). At March 31, 2025, approximately 25 percent of the recorded claim liability related to pending claims and approximately 75 percent related to future claims.

Legacy Matters
The Company is the subject of various complaints related to alleged groundwater contamination based on decades-old sales and applications of certain agricultural chemical products ("Groundwater Matters"). At March 31, 2025, the total liability related to the probable and estimable settlement of alleged Groundwater Matters was $155 million ($155 million at December 31, 2024), which was included in “Accrued and other current liabilities” and "Other noncurrent obligations" in the consolidated balance sheets.

The Company is also the subject of other groundwater contamination complaints, including claims related to 1,4-dioxane. The Company continues to defend itself in this litigation and it has determined that the Company's exposure to liability, if any, is not probable or estimable at March 31, 2025.

Separately, on October 10, 2024, the Company executed a settlement agreement related to arbitration for historical product claims from a divested business. As a result, the Company recorded a pretax charge of $75 million in the third quarter of 2024, which was paid in the fourth quarter of 2024. Arbitration on the matter was concluded on March 11, 2025, and, as a result, the Company recorded an additional pretax charge of $98 million in the first quarter of 2025, included in "Cost of sales" in the consolidated statements of income, related to Corporate, and included in "Accounts payable - Other" in the consolidated balance sheets at March 31, 2025.
Gain Contingency - Dow v. Nova Chemicals Corporation Ethylene Asset Matter
As a result of a 2019 damages judgment related to the ethylene asset matter, Nova Chemicals Corporation was ordered to pay the Company $1.43 billion Canadian dollars (equivalent to approximately $1.08 billion U.S. dollars), for which the Company received payment in October 2019 and March 2020. At March 31, 2025, $201 million ($201 million at December 31, 2024) was included in "Other noncurrent obligations" in the Company's consolidated balance sheets related to the disputed portion of the damages judgment.

On April 7, 2025, the Court of King's Bench (”Court") in Alberta, Canada, issued a ruling awarding the Company additional compensation for damages incurred through 2018. This ruling builds on the previous $1.08 billion U.S. dollar payout judgment. Dow expects to receive additional cash proceeds exceeding $1 billion U.S. dollars later in 2025. The Court found that Nova failed to operate the companies' jointly-owned ethylene asset in Joffre, Alberta, Canada at full capacity and, furthermore, that Nova violated several contractual agreements related to the Company receiving its share of the asset’s ethylene production. These actions deprived the Company of millions of pounds of ethylene. Nova will appeal the ruling. Although the Company is confident of its chances of defending the damages award on appeal, the Company has not recorded a gain as a result of the ruling.

Guarantees
The following table provides a summary of the final expiration, maximum future payments and recorded liability included in the consolidated balance sheets for guarantees:

GuaranteesMar 31, 2025Dec 31, 2024
In millionsFinal
Expiration		Maximum
Future Payments 		Recorded Liability Final
Expiration		Maximum
Future Payments 		Recorded Liability
Guarantees2038$1,661 $150 2038$1,456 $155 

Guarantees arise during the ordinary course of business from relationships with customers, accounts receivable facilities and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company to make payments to the beneficiary of the guarantee. The majority of the Company’s guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than one year to 13 years. The Company’s current expectation is that future payment or performance related to the non-performance of others is considered remote.

The Company maintains accounts receivable facilities with various financial institutions, with committed and uncommitted facilities in the United States and a committed facility in Europe. Under the terms of the Programs, the Company continues to service the receivables from the customers, but retains no interest in the receivables, and remits payment to the financial institutions. The Company also has access to accounts receivable discounting facilities, under which receivables are transferred with limited recourse. The Company’s maximum guaranteed liability for the accounts receivable facilities is $444 million at March 31, 2025 ($239 million at December 31, 2024). The Company expects receivable collections and remittances to occur within the next six months.

TDCC has entered into guarantee agreements related to Sadara, a nonconsolidated affiliate. Sadara reached an agreement with its lenders to re-profile its outstanding project financing debt in the first quarter of 2021. In conjunction with the debt re-profiling, TDCC entered into a guarantee of up to approximately $1.3 billion of Sadara’s debt, proportionate to the Company's 35 percent ownership interest. The debt re-profiling also includes a grace period until June 2026, during which Sadara is obligated to make interest-only payments which are guaranteed by TDCC in proportion to the Company’s 35 percent ownership interest. The Company does not expect to be required to perform under the guarantees. As part of the debt re-profiling, Sadara established a $500 million revolving credit facility guaranteed by Dow, which would be used to fund Dow’s pro-rata share of any potential shortfall during the grace period.
v3.25.1
LEASES (Notes)
 3 Months Ended
Mar. 31, 2025
Leases [Abstract]  
Lessee, Operating And Finance Leases LEASES
For additional information on the Company's leases, see Note 16 to the Consolidated Financial Statements included in the 2024 10-K.

The components of lease cost for operating and finance leases for the three months ended March 31, 2025 and 2024 were as follows:

Lease CostThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Operating lease cost$106 $107 
Finance lease cost
Amortization of right-of-use assets - finance32 27 
Interest on lease liabilities - finance12 10 
Total finance lease cost44 37 
Short-term lease cost80 74 
Variable lease cost255 258 
Sublease income(2)(2)
Total lease cost$483 $474 

The following table provides supplemental cash flow and other information related to leases:

Other Lease InformationThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases$112 $116 
Operating cash flows for finance leases$12 $10 
Financing cash flows for finance leases$29 $30 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases$110 $100 
Finance leases$65 $70 
v3.25.1
Accumulated Other Comprehensive Loss (Notes)
 3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Comprehensive Income (Loss) Note ACCUMULATED OTHER COMPREHENSIVE LOSS
The changes in each component of accumulated other comprehensive loss ("AOCL") for the three months ended March 31, 2025 and 2024 were as follows:

Accumulated Other Comprehensive LossThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Unrealized Gains (Losses) on Investments
Beginning balance$(243)$(253)
Unrealized gains (losses) on investments40 15 
Tax (expense) benefit(7)(18)
Net unrealized gains (losses) on investments33 (3)
(Gains) losses reclassified from AOCL to net income (loss) 1
(1)(4)
Tax expense (benefit) 2
— 1 
Net (gains) losses reclassified from AOCL to net income (loss)(1)(3)
Other comprehensive income (loss), net of tax32 (6)
Ending balance$(211)$(259)
Cumulative Translation Adjustments
Beginning balance$(2,063)$(1,891)
Gains (losses) on foreign currency translation126 (116)
Tax (expense) benefit3 (3)
Net gains (losses) on foreign currency translation129 (119)
(Gains) losses reclassified from AOCL to net income (loss) 3
(7)(3)
Other comprehensive income (loss), net of tax122 (122)
Ending balance$(1,941)$(2,013)
Pension and Other Postretirement Benefit Plans
Beginning balance$(5,720)$(5,486)
Gains (losses) arising during the period— (1)
Amortization of net loss and prior service credits reclassified from AOCL to net income (loss) 4
26 22 
Tax expense (benefit) 2
(6)(4)
Net loss and prior service credits reclassified from AOCL to net income (loss)20 18 
Other comprehensive income (loss), net of tax20 17 
Ending balance$(5,700)$(5,469)
Derivative Instruments
Beginning balance$(84)$(51)
Gains (losses) on derivative instruments(15)(33)
Tax (expense) benefit(2)3 
Net gains (losses) on derivative instruments(17)(30)
(Gains) losses reclassified from AOCL to net income (loss) 5
(4)10 
Tax expense (benefit) 2
1 (2)
Net (gains) losses reclassified from AOCL to net income (loss)(3)8 
Other comprehensive income (loss), net of tax(20)(22)
Ending balance$(104)$(73)
Total AOCL ending balance$(7,956)$(7,814)
1.Reclassified to "Net sales" and "Sundry income (expense) - net."
2.Reclassified to "Credit for income taxes."
3.Reclassified to "Sundry income (expense) - net."
4.These AOCL components are included in the computation of net periodic benefit cost (credit) of the Company's defined benefit pension and other postretirement benefit plans. See Note 14 for additional information.
5.Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."
Stockholders' Equity Note Disclosure [Text Block]
The changes in each component of accumulated other comprehensive loss ("AOCL") for the three months ended March 31, 2025 and 2024 were as follows:

Accumulated Other Comprehensive LossThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Unrealized Gains (Losses) on Investments
Beginning balance$(243)$(253)
Unrealized gains (losses) on investments40 15 
Tax (expense) benefit(7)(18)
Net unrealized gains (losses) on investments33 (3)
(Gains) losses reclassified from AOCL to net income (loss) 1
(1)(4)
Tax expense (benefit) 2
— 1 
Net (gains) losses reclassified from AOCL to net income (loss)(1)(3)
Other comprehensive income (loss), net of tax32 (6)
Ending balance$(211)$(259)
Cumulative Translation Adjustments
Beginning balance$(2,063)$(1,891)
Gains (losses) on foreign currency translation126 (116)
Tax (expense) benefit3 (3)
Net gains (losses) on foreign currency translation129 (119)
(Gains) losses reclassified from AOCL to net income (loss) 3
(7)(3)
Other comprehensive income (loss), net of tax122 (122)
Ending balance$(1,941)$(2,013)
Pension and Other Postretirement Benefit Plans
Beginning balance$(5,720)$(5,486)
Gains (losses) arising during the period— (1)
Amortization of net loss and prior service credits reclassified from AOCL to net income (loss) 4
26 22 
Tax expense (benefit) 2
(6)(4)
Net loss and prior service credits reclassified from AOCL to net income (loss)20 18 
Other comprehensive income (loss), net of tax20 17 
Ending balance$(5,700)$(5,469)
Derivative Instruments
Beginning balance$(84)$(51)
Gains (losses) on derivative instruments(15)(33)
Tax (expense) benefit(2)3 
Net gains (losses) on derivative instruments(17)(30)
(Gains) losses reclassified from AOCL to net income (loss) 5
(4)10 
Tax expense (benefit) 2
1 (2)
Net (gains) losses reclassified from AOCL to net income (loss)(3)8 
Other comprehensive income (loss), net of tax(20)(22)
Ending balance$(104)$(73)
Total AOCL ending balance$(7,956)$(7,814)
1.Reclassified to "Net sales" and "Sundry income (expense) - net."
2.Reclassified to "Credit for income taxes."
3.Reclassified to "Sundry income (expense) - net."
4.These AOCL components are included in the computation of net periodic benefit cost (credit) of the Company's defined benefit pension and other postretirement benefit plans. See Note 14 for additional information.
5.Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."
v3.25.1
NONCONTROLLING INTERESTS Noncontrolling Interests
 3 Months Ended
Mar. 31, 2025
Noncontrolling Interest [Abstract]  
Noncontrolling Interest Disclosure [Text Block] NONCONTROLLING INTERESTS
Ownership interests in the Company's subsidiaries held by parties other than the Company are presented separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the face of the consolidated statements of income.

The following table summarizes the activity for equity attributable to noncontrolling interests for the three months ended March 31, 2025 and 2024:

Noncontrolling InterestsThree Months Ended

In millions
Mar 31, 2025Mar 31, 2024
Balance at beginning of period$496 $501 
Net income attributable to noncontrolling interests17 22 
Distributions to noncontrolling interests(22)(14)
Cumulative translation adjustments16 (16)
Other— (1)
Balance at end of period$507 $492 
v3.25.1
PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS
 3 Months Ended
Mar. 31, 2025
Retirement Benefits [Abstract]  
Pension and Other Postretirement Benefits Disclosure [Text Block] PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
A summary of the Company's pension and other postretirement benefit plans can be found in Note 19 to the Consolidated Financial Statements included in the 2024 10-K. The following table provides the components of the Company's net periodic benefit cost (credit) for all significant plans:

Net Periodic Benefit Cost (Credit) for All Significant Plans Three Months Ended
In millionsMar 31, 2025Mar 31, 2024
Defined Benefit Pension Plans
Service cost$10 $14 
Interest cost 246 252 
Expected return on plan assets (319)(346)
Amortization of prior service credit(3)(3)
Amortization of net loss40 35 
Net periodic benefit credit$(26)$(48)
Other Postretirement Benefit Plans
Service cost $1 $1 
Interest cost 9 11 
Amortization of net gain(11)(10)
Net periodic benefit cost (credit)$(1)$2 

Net periodic benefit cost (credit), other than the service cost component, is included in "Sundry income (expense) - net" in the consolidated statements of income.
v3.25.1
STOCK-BASED COMPENSATION
 3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Share-based Payment Arrangement [Text Block] STOCK-BASED COMPENSATION
A summary of the Company's stock-based compensation plans can be found in Note 20 to the Consolidated Financial Statements included in the 2024 10-K.

Stock Incentive Plan
The Company grants stock-based compensation to employees and non-employee directors under the 2019 Stock Incentive Plan, as amended. Most of the Company's stock-based compensation awards are granted in the first quarter of each year.

In the first quarter of 2025, Dow Inc. granted the following stock-based compensation awards to employees:
•1.8 million stock options with a weighted-average exercise price of $38.34 per share and a weighted-average fair value of $8.27 per share;
•3.0 million restricted stock units with a weighted-average fair value of $38.34 per share; and
•2.1 million performance stock units with a weighted-average fair value of $38.46 per share.

Employee Stock Purchase Plan
The Dow Inc. 2021 Employee Stock Purchase Plan (the "2021 ESPP") was adopted by the Dow Inc. Board on February 11, 2021, and approved by stockholders at the Company's annual meeting on April 15, 2021. Under the 2025 annual offering of the 2021 ESPP, most employees will be eligible to purchase shares of common stock of Dow Inc. valued at up to 10 percent of their annual total base salary or wages. The number of shares purchased is determined using the amount contributed by the employee divided by the plan price. The plan price of the stock is equal to 85 percent of the fair market value (closing price) of the common stock at March 31, 2025 (beginning) or October 3, 2025 (ending) of the offering period, whichever is lower.

In the first quarter of 2025, employees subscribed to the right to purchase approximately 3.2 million shares under the 2021 ESPP. The plan price is fixed upon the close of the offering period and will be determined in the fourth quarter of 2025. The shares will be delivered to employees in the fourth quarter of 2025.
v3.25.1
Financial Instruments (Notes)
 3 Months Ended
Mar. 31, 2025
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments FINANCIAL INSTRUMENTS
A summary of the Company's financial instruments, risk management policies, derivative instruments and hedging activities can be found in Note 21 to the Consolidated Financial Statements included in the 2024 10-K.

Refer to Note 17 for a summary of the fair value of financial instruments at March 31, 2025 and December 31, 2024.

Debt Securities
The Company's investments in debt securities are primarily classified as available-for-sale. The following table provides investing results from available-for-sale securities for the three months ended March 31, 2025 and 2024:

Investing ResultsThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Proceeds from sales of available-for-sale securities$154 $721 
Gross realized gains$2 $9 
Gross realized losses $(1)$(5)
The following table summarizes contractual maturities of the Company's investments in debt securities:

Contractual Maturities of Debt Securities at Mar 31, 2025
 CostFair Value
In millions
Within one year$110 $100 
One to five years1,188 1,094 
Six to ten years426 412 
After ten years524 425 
Total$2,248 $2,031 

Equity Securities
There were no material adjustments to the carrying value of the not readily determinable investments for impairment or observable price changes for the three months ended March 31, 2025. There was $3 million of net unrealized losses recognized in earnings on equity securities for the three months ended March 31, 2025 (no unrealized gains or losses for the three months ended March 31, 2024).

Investments in Equity SecuritiesMar 31, 2025Dec 31, 2024
In millions
Readily determinable fair value$11 $14 
Not readily determinable fair value$149 $153 

Derivative Instruments
The notional amounts of the Company's derivative instruments at March 31, 2025 and December 31, 2024 were as follows:

Notional Amounts 1
Mar 31, 2025Dec 31, 2024
In millions
Derivatives designated as hedging instruments:
Interest rate contracts$757 $1,870 
Foreign currency contracts$4,080 $3,144 
Derivatives not designated as hedging instruments:
Interest rate contracts$44 $14 
Foreign currency contracts$19,738 $9,244 
1.Notional amounts represent the absolute value of open derivative positions at the end of the period. Multi-leg option positions are reflected at the maximum notional position at expiration.

The notional amounts of the Company's commodity derivatives at March 31, 2025 and December 31, 2024 were as follows:

Commodity Notionals 1
Mar 31, 2025Dec 31, 2024Notional Volume Unit
Derivatives designated as hedging instruments:
Hydrocarbon derivatives5.0 3.2 million barrels of oil equivalent
Derivatives not designated as hedging instruments:
Hydrocarbon derivatives1.0 1.1 million barrels of oil equivalent
1.Notional amounts represent the net volume of open derivative positions outstanding at the end of the period.

Maturity Dates of Derivatives Designated as Hedging InstrumentsYear
Interest rate contracts2027
Foreign currency contracts2026
Commodity contracts2028
The following table provides the fair value and balance sheet classification of derivative instruments at March 31, 2025 and December 31, 2024:

Fair Value of Derivative InstrumentsMar 31, 2025Dec 31, 2024
In millionsGross
Counterparty and Cash Collateral Netting 1
Net 2
Gross
Counterparty and Cash Collateral Netting 1
Net 2
Asset derivatives
Derivatives designated as hedging instruments:
Interest rate contracts 3
$27 $(18)$9 $20 $(20)$— 
Interest rate contracts 4
25 (19)6 — — — 
Foreign currency contracts 3
34 (33)1 33 (15)18 
Foreign currency contracts 4
22 (21)1 — — — 
Commodity contracts 3
55 (25)30 25 (14)11 
Commodity contracts 4
44 (37)7 46 (36)10 
Total$207 $(153)$54 $124 $(85)$39 
Derivatives not designated as hedging instruments:
Interest rate contracts 4
$1 $(1)$— $— $— $— 
Foreign currency contracts 3
25 (24)1 74 (16)58 
Commodity contracts 3
13 (1)12 16 (1)15 
Commodity contracts 4
4 (3)1 4 (3)1 
Total$43 $(29)$14 $94 $(20)$74 
Total asset derivatives $250 $(182)$68 $218 $(105)$113 
Liability derivatives
Derivatives designated as hedging instruments:
Interest rate contracts 5
$18 $(18)$— $46 $(20)$26 
Interest rate contracts 6
19 (19)— — — — 
Foreign currency contracts 5
97 (33)64 75 (15)60 
Foreign currency contracts 6
53 (21)32 40 — 40 
Commodity contracts 5
36 (26)10 16 (14)2 
Commodity contracts 6
39 (37)2 37 (36)1 
Total$262 $(154)$108 $214 $(85)$129 
Derivatives not designated as hedging instruments:
Interest rate contracts 5
$— $— $— $1 $— $1 
Interest rate contracts 6
1 (1)— — — — 
Foreign currency contracts 5
178 (24)154 27 (16)11 
Commodity contracts 5
4 (1)3 8 (1)7 
Commodity contracts 6
3 (3)— 4 (3)1 
Total$186 $(29)$157 $40 $(20)$20 
Total liability derivatives $448 $(183)$265 $254 $(105)$149 
1.Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.
2.Represents the net amounts included in the consolidated balance sheets.
3.Included in "Other current assets" in the consolidated balance sheets.
4.Included in "Deferred charges and other assets" in the consolidated balance sheets.
5.Included in "Accrued and other current liabilities" in the consolidated balance sheets.
6.Included in "Other noncurrent obligations" in the consolidated balance sheets.
Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash collateral of $12 million at March 31, 2025 ($16 million at December 31, 2024). No cash collateral was posted by counterparties with the Company at March 31, 2025 and December 31, 2024.

The following table summarizes the gain (loss) of derivative instruments in the consolidated statements of income and comprehensive income for the three months ended March 31, 2025 and 2024:

Effect of Derivative Instruments
Gain (loss) recognized in OCI 1
Gain (loss) recognized in income 2
Three Months EndedThree Months Ended
In millionsMar 31, 2025Mar 31, 2024Mar 31, 2025Mar 31, 2024
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate contracts 3, 4
$— $— $20 $— 
Excluded components 3, 5
(5)(38)— — 
Cash flow hedges:
Interest rate contracts 3
1 1 (1)(2)
Foreign currency contracts 6
(6)(13)2 1 
Commodity contracts 6
6 15 4 (8)
Excluded components 5, 6
— (6)(1)(1)
Net foreign investment hedges:
Foreign currency contracts(27)2 — — 
Excluded components 5, 7
27 6 7 3 
Total derivatives designated as hedging instruments$(4)$(33)$31 $(7)
Derivatives not designated as hedging instruments:
Foreign currency contracts 7
— — (56)31 
Commodity contracts 6
— — (5)8 
Total return swap 6
— — (11)22 
Total derivatives not designated as hedging instruments$— $— $(72)$61 
Total derivatives$(4)$(33)$(41)$54 
1.OCI is defined as other comprehensive income (loss).
2.Pretax amounts.
3.Included in "Interest expense and amortization of debt discount" in the consolidated statements of income.
4.Gain (loss) recognized in income of derivatives is offset by gain (loss) recognized in income of the hedged item.
5.The excluded components are related to the time value of the derivatives designated as hedges.
6.Included in "Cost of sales" in the consolidated statements of income.
7.Included in "Sundry income (expense) - net" in the consolidated statements of income.

The following table provides the net after-tax gain (loss) expected to be reclassified from AOCL to income within the next 12 months:

Expected Reclassifications from AOCL within the next 12 monthsMar 31, 2025
In millions
Cash flow hedges:
Interest rate contracts$(3)
Commodity contracts$13 
Foreign currency contracts$(1)
Excluded components$(3)
Net foreign investment hedges:
Excluded components$25 
v3.25.1
FAIR VALUE MEASUREMENTS (Notes)
 3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block] FAIR VALUE MEASUREMENTS
A summary of the Company's recurring and nonrecurring fair value measurements can be found in Note 22 to the Consolidated Financial Statements included in the 2024 10-K.

Fair Value Measurements on a Recurring Basis
The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis:

Fair Value Measurements on a Recurring BasisMar 31, 2025Dec 31, 2024
In millionsFair Value LevelCostGainLossFair ValueCostGainLossFair Value
Assets at fair value:
Cash equivalents:
Held-to-maturity securities 1
Level 2$114 $— $— $114 $96 $— $— $96 
Money market fundsLevel 2567 — — 567 1,164 — — 1,164 
Marketable securities 2
Level 2393 — (53)340 453 — (70)383 
Other investments:
Debt securities: 3
Government debt 4
Level 21,107 13 (115)1,005 1,103 13 (123)993 
Corporate bondsLevel 118 — (1)17 18 — (1)17 
Corporate bondsLevel 2923 6 (85)844 954 6 (88)872 
Corporate bondsLevel 3200 — (35)165 200 — (49)151 
Equity securities 3, 5
Level 14 7 — 11 4 10 — 14 
Derivatives relating to: 6
Interest ratesLevel 2— 53 — 53 — 20 — 20 
Foreign currencyLevel 2— 81 — 81 — 107 — 107 
CommoditiesLevel 1— 8 — 8 — 4 — 4 
CommoditiesLevel 2— 108 — 108 — 87 — 87 
Total assets at fair value$3,313 $3,908 
Liabilities at fair value:
Long-term debt including debt due within one year 7
Level 2$(16,434)$1,520 $(462)$(15,376)$(16,208)$1,487 $(484)$(15,205)
Guarantee liability 8
Level 3(149)(155)
Derivatives relating to: 6
Interest ratesLevel 2— — (38)(38)— — (47)(47)
Foreign currencyLevel 2— — (328)(328)— — (142)(142)
CommoditiesLevel 1— — (2)(2)— — (1)(1)
CommoditiesLevel 2— — (80)(80)— — (64)(64)
Total liabilities at fair value$(15,973)$(15,614)
1.The Company's held-to-maturity securities primarily relate to treasury bills and time deposits. At March 31, 2025, $97 million is included in "Cash and cash equivalents" ($96 million at December 31, 2024) and $17 million is included in "Other current assets" (zero at December 31, 2024) in the consolidated balance sheets.
2.The Company’s investments in marketable securities are included in “Other current assets” in the consolidated balance sheets.
3.The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.
4.U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations.
5.Equity securities with a readily determinable fair value.
6.See Note 16 for classification of derivatives in the consolidated balance sheets.
7.Cost includes fair value hedge adjustment gains of $29 million at March 31, 2025 and $9 million at December 31, 2024 on $5,255 million of debt at March 31, 2025 and $5,129 million at December 31, 2024.
8.Estimated liability for TDCC's guarantee of Sadara's debt which is included in "Other noncurrent obligations" in the consolidated balance sheets.

Cost approximates fair value for all other financial instruments.
For equity securities calculated at net asset value per share (or its equivalent), the Company had $87 million in private market securities and $14 million in real estate at March 31, 2025 ($90 million in private market securities and $15 million in real estate at December 31, 2024). There are no redemption restrictions and the unfunded commitments on these investments were $80 million at March 31, 2025 and $81 million at December 31, 2024.

For assets classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The level 3 asset values represent the fair value of an investment in a corporate bond, accounted for as a debt security.

For liabilities classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Company’s accrued liability related to the guarantee of Sadara’s debt is in proportion to the Company’s 35 percent ownership interest in Sadara. The estimated fair value of the guarantee was calculated using a "with" and "without" method. The fair value of the debt was calculated "with" the guarantee less the fair value of the debt "without" the guarantee. The "with" and "without" values were calculated using a discounted cash flow method based on contractual cash flows as well as projected prepayments made on the debt by Sadara.

Fair Value Measurements on a Nonrecurring Basis
2023 Restructuring Program
In the first quarter of 2025, the Company recorded impairment charges of $5 million for asset write-downs and write-offs, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure.
v3.25.1
SEGMENTS AND GEOGRAPHIC REGIONS (Notes)
 3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Segments and Geographic Regions [Text Block] SEGMENTS AND GEOGRAPHIC REGIONS
Sales to external customers, which are attributed to geographic regions based on customer location, were as follows:

Sales to External Customers by Geographic RegionThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
United States$3,946 $3,829 
EMEAI3,274 3,484 
Rest of World3,211 3,452 
Total$10,431 $10,765 

Long-lived assets, which are attributed to geographic regions based on asset location, were as follows:

Long-Lived Assets by Geographic RegionMar 31, 2025Dec 31, 2024
In millions
United States$15,176 $15,216 
EMEAI2,826 2,726 
Rest of World4,328 4,062 
Total$22,330 $22,004 

Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the chief executive officer, chief operating officer, chief financial officer, general counsel and corporate secretary, and senior vice president of corporate development, together the "executive committee" and CODM, assesses performance and allocates resources. The CODM compares quarterly results to both the year-ago and sequential periods to assess performance and allocate resources to each segment. The Company defines Operating EBIT as earnings (i.e., "Income (loss) before income taxes") before interest, excluding the impact of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate.
Segment Operating EBIT 1
Pack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment Total
In millions
Three months ended Mar 31, 2025
Net sales$5,310 $2,855 $2,071 $10,236 
Cost of sales4,765 2,822 1,845 9,432 
SARD 2
240 127 151 518 
Equity in earnings (losses) of nonconsolidated affiliates39 (58)— (19)
Other segment income (expense) items 3
(2)24 (26)(4)
Segment Operating EBIT 4
$342 $(128)$49 $263 
Three months ended Mar 31, 2024
Net sales$5,430 $3,008 $2,152 $10,590 
Cost of sales4,597 2,776 1,894 9,267 
SARD 2
255 136 197 588 
Equity in earnings (losses) of nonconsolidated affiliates25 (15)6 16 
Other segment income (expense) items 3
2 6 (26)(18)
Segment Operating EBIT 4
$605 $87 $41 $733 
1.Significant expense categories are presented on an operating basis, net of the impact of significant items.
2.SARD includes selling, general and administrative and research and development expenses.
3.Other segment items includes amortization of intangibles and sundry income (expense) - net.
4.Segment Operating EBIT for TDCC for the three months ended March 31, 2025 and 2024 is substantially the same as that of Dow Inc. and therefore is not disclosed separately in the table above. A reconciliation of "Segment Operating EBIT" to "Income before income taxes" is provided in the following table.

Reconciliation of "Segment Operating EBIT" to "Income (Loss) Before Income Taxes"
Three Months Ended
In millionsMar 31, 2025Mar 31, 2024
Segment Operating EBIT$263 $733 
+ Corporate Operating EBIT(33)(59)
+ Interest income28 65 
- Interest expense and amortization of debt discount216 199 
+ Significant items(416)(91)
Income (loss) before income taxes$(374)$449 

Other Segment InformationPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment Total
Corp. 1
Total
In millions
Three months ended Mar 31, 2025
Net sales$5,310 $2,855 $2,071 $10,236 $195 $10,431 
Depreciation and amortization$360 $146 $200 $706 $8 $714 
Capital expenditures$515 $129 $41 $685 $— $685 
Operating EBIT$342 $(128)$49 $263 $(33)$230 
Three months ended Mar 31, 2024
Net sales$5,430 $3,008 $2,152 $10,590 $175 $10,765 
Depreciation and amortization$371 $147 $193 $711 $9 $720 
Capital expenditures$469 $162 $83 $714 $— $714 
Operating EBIT$605 $87 $41 $733 $(59)$674 
1.Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. Net sales for Corporate are primarily related to insurance operations. Corporate expenses are primarily related to insurance operations, salaries and wages and non-business aligned environmental and legal costs.
Segment Asset InformationPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment TotalCorp.Total
In millions
March 31, 2025
Total assets$28,966 $11,830 $11,370 $52,166 $5,333 $57,499 
Investments in nonconsolidated affiliates$740 $348 $142 $1,230 $45 $1,275 
December 31, 2024
Total assets$29,034 $11,928 $11,170 $52,132 $5,180 $57,312 
Investments in nonconsolidated affiliates$711 $367 $146 $1,224 $42 $1,266 

The following tables summarize the pretax impact of significant items by segment excluded from Operating EBIT:

Significant Items by Segment
Three Months Ended Mar 31, 2025
Pack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment TotalCorp.Total
In millions
Restructuring, implementation and efficiency costs, and asset related charges - net 1
$— $(1)$— $(1)$(50)$(51)
2025 Restructuring Program 2
— — — — (207)(207)
Loss on early extinguishment of debt 3
— — — — (60)(60)
Indemnification and other transaction related costs 4
— — — — (98)(98)
Total$— $(1)$— $(1)$(415)$(416)
1.Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. Also includes impairment charges related to the write-down of certain manufacturing assets, partially offset by an asset related credit adjustment. See Note 4 for additional information.
2.Severance and related benefit costs associated with the Company's 2025 Restructuring Program. See Note 4 for additional information.
3.The Company retired outstanding long-term debt resulting in a loss on early extinguishment. See Note 9 for additional information.
4.Includes charges related to an arbitration settlement agreement for historical product claims from a divested business. See Note 10 for additional information.

Significant Items by Segment
Three Months Ended Mar 31, 2024
Pack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment TotalCorp.Total
In millions
Restructuring, implementation and efficiency costs, and asset related charges - net 1
$(37)$(8)$— $(45)$(46)$(91)
Total$(37)$(8)$— $(45)$(46)$(91)
1.Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. Also includes impairment charges related to the write-down of certain manufacturing assets.
v3.25.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Pay vs Performance Disclosure    
Net income (loss) available for The Dow Chemical Company common stockholder $ (307) $ 516
v3.25.1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.1
REVENUE (Tables)
 3 Months Ended
Mar. 31, 2025
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue [Table Text Block]
Disaggregation of Revenue
The Company disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See details in the tables below:

Net Trade Sales by Segment and BusinessThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Hydrocarbons & Energy$1,578 $1,467 
Packaging and Specialty Plastics3,732 3,963 
Packaging & Specialty Plastics$5,310 $5,430 
Industrial Solutions $1,054 $1,028 
Polyurethanes & Construction Chemicals1,797 1,977 
Other4 3 
Industrial Intermediates & Infrastructure$2,855 $3,008 
Coatings & Performance Monomers$845 $885 
Consumer Solutions1,226 1,267 
Performance Materials & Coatings$2,071 $2,152 
Corporate$195 $175 
Total$10,431 $10,765 

Net Trade Sales by Geographic RegionThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
U.S. & Canada$4,227 $4,130 
EMEAI 1
3,274 3,484 
Asia Pacific1,858 1,921 
Latin America1,072 1,230 
Total$10,431 $10,765 
1.Europe, Middle East, Africa and India.
Contract with Customer, Asset and Liability [Table Text Block]
The following table summarizes contract assets and liabilities at March 31, 2025 and December 31, 2024:

Contract Assets and LiabilitiesBalance Sheet ClassificationMar 31, 2025Dec 31, 2024
In millions
Accounts and notes receivable - tradeAccounts and notes receivable - trade$4,917 $4,756 
Contract assets - noncurrentDeferred charges and other assets$— $2 
Contract liabilities - currentAccrued and other current liabilities$207 $244 
Contract liabilities - noncurrent Other noncurrent obligations$1,459 $1,480 
v3.25.1
SUPPLEMENTARY INFORMATION (Tables)
 3 Months Ended
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Sundry Income, Net
Dow Inc. Sundry Income (Expense) – NetThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Non-operating pension and other postretirement benefit plan net credits 1
$38 $61 
Foreign exchange gains (losses) 2
7 (23)
Gain (loss) on sales of other assets and investments(3)9 
Loss on early extinguishment of debt 3
(60)— 
Other - net31 14 
Total sundry income (expense) – net$13 $61 
1.See Note 14 for additional information.
2.Foreign exchange losses for the three months ended March 31, 2024 relate primarily to exposures in the Egyptian pound and Argentine peso.
3.See Note 9 for additional information.
Schedule of Company-Owned Life Insurance
Other Investments
The Company has investments in company-owned life insurance policies, which are recorded at their cash surrender value as of each balance sheet date, as provided below:

Investments in Company-Owned Life InsuranceMar 31, 2025Dec 31, 2024
In millions
Gross cash value$544 $558 
Less: Existing drawdowns 1
200 — 
Investments in company-owned life insurance 2
$344 $558 
1.Classified as "Proceeds from sales and maturities of investments" in the consolidated statements of cash flows.
2.Classified as "Other investments" in the consolidated balance sheets.
v3.25.1
EARNINGS PER SHARE (Tables)
 3 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following tables provide earnings per share calculations for Dow Inc. for the three months ended March 31, 2025 and 2024. Earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries.

Net Income (Loss) for Earnings Per Share CalculationsThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Net income (loss)$(290)$538 
Net income attributable to noncontrolling interests17 22 
Net income attributable to participating securities 1
3 3 
Net income (loss) attributable to common stockholders$(310)$513 
1.Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares.

Earnings (Loss) Per Share - Basic and DilutedThree Months Ended
Dollars per shareMar 31, 2025Mar 31, 2024
Earnings (loss) per common share - basic$(0.44)$0.73 
Earnings (loss) per common share - diluted$(0.44)$0.73 

Share Count InformationThree Months Ended
Shares in millionsMar 31, 2025Mar 31, 2024
Weighted-average common shares outstanding - basic706.9 704.5 
Plus dilutive effect of equity compensation plans 1
— 1.0 
Weighted-average common shares outstanding - diluted706.9 705.5 
Stock units excluded from EPS calculations 2
14.9 8.8 
1.The three months ended March 31, 2025 reflect a net loss and, as such, the basic share count was used for purposes of calculating earnings per share on a diluted basis.
2.These outstanding stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.
v3.25.1
INVENTORIES (Tables)
 3 Months Ended
Mar. 31, 2025
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current [Table Text Block]
The following table provides a breakdown of inventories:

InventoriesMar 31, 2025Dec 31, 2024
In millions
Finished goods$3,947 $3,773 
Work in process1,368 1,323 
Raw materials847 822 
Supplies1,084 1,039 
Total$7,246 $6,957 
Adjustment of inventories to the LIFO basis(481)(413)
Total inventories$6,765 $6,544 
v3.25.1
Transfers and Servicing (Tables)
 3 Months Ended
Mar. 31, 2025
Transfers and Servicing [Abstract]  
Cash Flows related to Transfers of AR [Table Text Block]
The following table provides a summary of cash flows related to the Programs and the Facilities for the three months ended March 31, 2025 and 2024:

Cash Flows Related to Transfers of Accounts ReceivableThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Proceeds received from new transfers$514 $427 
Balances related to Transfers of AR
The following table provides the balances related to the Programs and the Facilities at March 31, 2025 and December 31, 2024:

Balances Related to Transfers of Accounts ReceivableMar 31, 2025Dec 31, 2024
In millions
Balance outstanding$535$287
Accounts receivable derecognized $511$278
Amounts recognized in the consolidated balance sheets:
    Accrued and other current liabilities 1
$24$9
1. Represents amounts collected from customers and not yet remitted by the Company.
v3.25.1
NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Tables)
 3 Months Ended
Mar. 31, 2025
Debt Disclosure [Abstract]  
Schedule of Short-term Debt
Notes PayableMar 31, 2025Dec 31, 2024
In millions
Notes payable to banks and other lenders$136$135
Period-end average interest rates28.93 %36.03 %
Schedule of Long-term Debt Instruments
Long-Term Debt
2025 Average Rate
Mar 31, 2025
2024 Average Rate
Dec 31, 2024
In millions
Promissory notes and debentures:
Final maturity 20255.63 %$333 5.63 %$333 
Final maturity 20284.80 %600 4.80 %600 
Final maturity 2029 1
7.53 %951 7.58 %1,368 
Final maturity 20302.10 %818 2.10 %818 
Final maturity 2031 and thereafter 1
5.41 %10,209 5.37 %9,192 
Other facilities:
Foreign currency notes and loans, various rates and maturities 1
2.18 %2,094 2.01 %2,540 
InterNotes®, varying maturities through 20534.34 %668 4.31 %661 
Medium-term notes, maturity 20254.75 %1 4.75 %1 
Finance lease obligations 2
985 939 
Unamortized debt discount and issuance costs(225)(244)
Long-term debt due within one year 3
(502)(497)
Long-term debt$15,932 $15,711 
1.Cost includes net fair value hedge adjustment gains of $29 million at March 31, 2025 ($9 million at December 31, 2024). See Note 16 for additional information.
2.See Note 11 for additional information.
3.Presented net of current portion of unamortized debt issuance costs.
Schedule of Maturities of Long-term Debt
Maturities of Long-Term Debt for Next Five Years at Mar 31, 2025
In millions
2025$472 
2026$149 
2027$746 
2028$702 
2029$1,045 
2030$911 
Schedule of Line of Credit Facilities
The following table summarizes the Company's credit facilities:

Committed and Available Credit Facilities at Mar 31, 2025
In millionsCommitted CreditAvailable CreditMaturity DateInterest
Five Year Competitive Advance and Revolving Credit Facility$5,000 $5,000 November 2028Floating rate
Bilateral Revolving Credit Facility200 200 September 2025Floating rate
Bilateral Revolving Credit Facility175 175 September 2025Floating rate
Bilateral Revolving Credit Facility300 300 November 2025Floating rate
Bilateral Revolving Credit Facility300 300 February 2026Floating rate
Bilateral Revolving Credit Facility100 100 March 2026Floating rate
Bilateral Revolving Credit Facility375 375 October 2026Floating rate
Bilateral Revolving Credit Facility150 150 November 2026Floating rate
Bilateral Revolving Credit Facility200 200 November 2026Floating rate
Bilateral Revolving Credit Facility250 250 March 2027Floating rate
Bilateral Revolving Credit Facility100 100 May 2027Floating rate
Bilateral Revolving Credit Facility350 350 June 2027Floating rate
Bilateral Revolving Credit Facility200 200 September 2027Floating rate
Bilateral Revolving Credit Facility100 100 October 2027Floating rate
Bilateral Revolving Credit Facility100 100 November 2027Floating rate
Bilateral Revolving Credit Facility100 100 March 2028Floating rate
Bilateral Revolving Credit Facility100 100 March 2028Floating rate
Bilateral Revolving Credit Facility300 300 May 2028Floating rate
Total committed and available credit facilities$8,400 $8,400 
v3.25.1
COMMITMENTS AND CONTINGENCIES (Tables)
 3 Months Ended
Mar. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Guarantor Obligations
The following table provides a summary of the final expiration, maximum future payments and recorded liability included in the consolidated balance sheets for guarantees:

GuaranteesMar 31, 2025Dec 31, 2024
In millionsFinal
Expiration		Maximum
Future Payments 		Recorded Liability Final
Expiration		Maximum
Future Payments 		Recorded Liability
Guarantees2038$1,661 $150 2038$1,456 $155 
v3.25.1
LEASES (Tables)
 3 Months Ended
Mar. 31, 2025
Guarantor Obligations [Line Items]  
Lease, Cost
The components of lease cost for operating and finance leases for the three months ended March 31, 2025 and 2024 were as follows:

Lease CostThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Operating lease cost$106 $107 
Finance lease cost
Amortization of right-of-use assets - finance32 27 
Interest on lease liabilities - finance12 10 
Total finance lease cost44 37 
Short-term lease cost80 74 
Variable lease cost255 258 
Sublease income(2)(2)
Total lease cost$483 $474 
Schedule of Supplemental Cash Flow Information Related to Leases
The following table provides supplemental cash flow and other information related to leases:

Other Lease InformationThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases$112 $116 
Operating cash flows for finance leases$12 $10 
Financing cash flows for finance leases$29 $30 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases$110 $100 
Finance leases$65 $70 
v3.25.1
Accumulated Other Comprehensive Loss (Tables)
 3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Accumulated Other Comprehensive Income (Loss)
The changes in each component of accumulated other comprehensive loss ("AOCL") for the three months ended March 31, 2025 and 2024 were as follows:

Accumulated Other Comprehensive LossThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Unrealized Gains (Losses) on Investments
Beginning balance$(243)$(253)
Unrealized gains (losses) on investments40 15 
Tax (expense) benefit(7)(18)
Net unrealized gains (losses) on investments33 (3)
(Gains) losses reclassified from AOCL to net income (loss) 1
(1)(4)
Tax expense (benefit) 2
— 1 
Net (gains) losses reclassified from AOCL to net income (loss)(1)(3)
Other comprehensive income (loss), net of tax32 (6)
Ending balance$(211)$(259)
Cumulative Translation Adjustments
Beginning balance$(2,063)$(1,891)
Gains (losses) on foreign currency translation126 (116)
Tax (expense) benefit3 (3)
Net gains (losses) on foreign currency translation129 (119)
(Gains) losses reclassified from AOCL to net income (loss) 3
(7)(3)
Other comprehensive income (loss), net of tax122 (122)
Ending balance$(1,941)$(2,013)
Pension and Other Postretirement Benefit Plans
Beginning balance$(5,720)$(5,486)
Gains (losses) arising during the period— (1)
Amortization of net loss and prior service credits reclassified from AOCL to net income (loss) 4
26 22 
Tax expense (benefit) 2
(6)(4)
Net loss and prior service credits reclassified from AOCL to net income (loss)20 18 
Other comprehensive income (loss), net of tax20 17 
Ending balance$(5,700)$(5,469)
Derivative Instruments
Beginning balance$(84)$(51)
Gains (losses) on derivative instruments(15)(33)
Tax (expense) benefit(2)3 
Net gains (losses) on derivative instruments(17)(30)
(Gains) losses reclassified from AOCL to net income (loss) 5
(4)10 
Tax expense (benefit) 2
1 (2)
Net (gains) losses reclassified from AOCL to net income (loss)(3)8 
Other comprehensive income (loss), net of tax(20)(22)
Ending balance$(104)$(73)
Total AOCL ending balance$(7,956)$(7,814)
1.Reclassified to "Net sales" and "Sundry income (expense) - net."
2.Reclassified to "Credit for income taxes."
3.Reclassified to "Sundry income (expense) - net."
4.These AOCL components are included in the computation of net periodic benefit cost (credit) of the Company's defined benefit pension and other postretirement benefit plans. See Note 14 for additional information.
5.Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."
v3.25.1
NONCONTROLLING INTERESTS Noncontrolling Interests (Tables)
 3 Months Ended
Mar. 31, 2025
Noncontrolling Interest [Abstract]  
Noncontrolling Interests [Table Text Block]
The following table summarizes the activity for equity attributable to noncontrolling interests for the three months ended March 31, 2025 and 2024:

Noncontrolling InterestsThree Months Ended

In millions
Mar 31, 2025Mar 31, 2024
Balance at beginning of period$496 $501 
Net income attributable to noncontrolling interests17 22 
Distributions to noncontrolling interests(22)(14)
Cumulative translation adjustments16 (16)
Other— (1)
Balance at end of period$507 $492 
v3.25.1
PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Tables)
 3 Months Ended
Mar. 31, 2025
Retirement Benefits [Abstract]  
Schedule of Net Benefit Costs [Table Text Block] The following table provides the components of the Company's net periodic benefit cost (credit) for all significant plans:
Net Periodic Benefit Cost (Credit) for All Significant Plans Three Months Ended
In millionsMar 31, 2025Mar 31, 2024
Defined Benefit Pension Plans
Service cost$10 $14 
Interest cost 246 252 
Expected return on plan assets (319)(346)
Amortization of prior service credit(3)(3)
Amortization of net loss40 35 
Net periodic benefit credit$(26)$(48)
Other Postretirement Benefit Plans
Service cost $1 $1 
Interest cost 9 11 
Amortization of net gain(11)(10)
Net periodic benefit cost (credit)$(1)$2 
v3.25.1
Financial Instruments (Tables)
 3 Months Ended
Mar. 31, 2025
Investments, Debt and Equity Securities [Abstract]  
Investing Results The following table provides investing results from available-for-sale securities for the three months ended March 31, 2025 and 2024:
Investing ResultsThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
Proceeds from sales of available-for-sale securities$154 $721 
Gross realized gains$2 $9 
Gross realized losses $(1)$(5)
Contractual Maturities of Debt Securities
The following table summarizes contractual maturities of the Company's investments in debt securities:

Contractual Maturities of Debt Securities at Mar 31, 2025
 CostFair Value
In millions
Within one year$110 $100 
One to five years1,188 1,094 
Six to ten years426 412 
After ten years524 425 
Total$2,248 $2,031 
Equity Securities with and without Readily Determinable Fair Value
Investments in Equity SecuritiesMar 31, 2025Dec 31, 2024
In millions
Readily determinable fair value$11 $14 
Not readily determinable fair value$149 $153 
Schedule of Notional Amounts of Outstanding Derivative Positions
The notional amounts of the Company's derivative instruments at March 31, 2025 and December 31, 2024 were as follows:

Notional Amounts 1
Mar 31, 2025Dec 31, 2024
In millions
Derivatives designated as hedging instruments:
Interest rate contracts$757 $1,870 
Foreign currency contracts$4,080 $3,144 
Derivatives not designated as hedging instruments:
Interest rate contracts$44 $14 
Foreign currency contracts$19,738 $9,244 
1.Notional amounts represent the absolute value of open derivative positions at the end of the period. Multi-leg option positions are reflected at the maximum notional position at expiration.

The notional amounts of the Company's commodity derivatives at March 31, 2025 and December 31, 2024 were as follows:

Commodity Notionals 1
Mar 31, 2025Dec 31, 2024Notional Volume Unit
Derivatives designated as hedging instruments:
Hydrocarbon derivatives5.0 3.2 million barrels of oil equivalent
Derivatives not designated as hedging instruments:
Hydrocarbon derivatives1.0 1.1 million barrels of oil equivalent
1.Notional amounts represent the net volume of open derivative positions outstanding at the end of the period.
Schedule of Derivative Instruments
Maturity Dates of Derivatives Designated as Hedging InstrumentsYear
Interest rate contracts2027
Foreign currency contracts2026
Commodity contracts2028
Schedule of Fair Values of Derivative Instruments
The following table provides the fair value and balance sheet classification of derivative instruments at March 31, 2025 and December 31, 2024:

Fair Value of Derivative InstrumentsMar 31, 2025Dec 31, 2024
In millionsGross
Counterparty and Cash Collateral Netting 1
Net 2
Gross
Counterparty and Cash Collateral Netting 1
Net 2
Asset derivatives
Derivatives designated as hedging instruments:
Interest rate contracts 3
$27 $(18)$9 $20 $(20)$— 
Interest rate contracts 4
25 (19)6 — — — 
Foreign currency contracts 3
34 (33)1 33 (15)18 
Foreign currency contracts 4
22 (21)1 — — — 
Commodity contracts 3
55 (25)30 25 (14)11 
Commodity contracts 4
44 (37)7 46 (36)10 
Total$207 $(153)$54 $124 $(85)$39 
Derivatives not designated as hedging instruments:
Interest rate contracts 4
$1 $(1)$— $— $— $— 
Foreign currency contracts 3
25 (24)1 74 (16)58 
Commodity contracts 3
13 (1)12 16 (1)15 
Commodity contracts 4
4 (3)1 4 (3)1 
Total$43 $(29)$14 $94 $(20)$74 
Total asset derivatives $250 $(182)$68 $218 $(105)$113 
Liability derivatives
Derivatives designated as hedging instruments:
Interest rate contracts 5
$18 $(18)$— $46 $(20)$26 
Interest rate contracts 6
19 (19)— — — — 
Foreign currency contracts 5
97 (33)64 75 (15)60 
Foreign currency contracts 6
53 (21)32 40 — 40 
Commodity contracts 5
36 (26)10 16 (14)2 
Commodity contracts 6
39 (37)2 37 (36)1 
Total$262 $(154)$108 $214 $(85)$129 
Derivatives not designated as hedging instruments:
Interest rate contracts 5
$— $— $— $1 $— $1 
Interest rate contracts 6
1 (1)— — — — 
Foreign currency contracts 5
178 (24)154 27 (16)11 
Commodity contracts 5
4 (1)3 8 (1)7 
Commodity contracts 6
3 (3)— 4 (3)1 
Total$186 $(29)$157 $40 $(20)$20 
Total liability derivatives $448 $(183)$265 $254 $(105)$149 
1.Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.
2.Represents the net amounts included in the consolidated balance sheets.
3.Included in "Other current assets" in the consolidated balance sheets.
4.Included in "Deferred charges and other assets" in the consolidated balance sheets.
5.Included in "Accrued and other current liabilities" in the consolidated balance sheets.
6.Included in "Other noncurrent obligations" in the consolidated balance sheets.
Derivative Instruments, Gain (Loss)
The following table summarizes the gain (loss) of derivative instruments in the consolidated statements of income and comprehensive income for the three months ended March 31, 2025 and 2024:

Effect of Derivative Instruments
Gain (loss) recognized in OCI 1
Gain (loss) recognized in income 2
Three Months EndedThree Months Ended
In millionsMar 31, 2025Mar 31, 2024Mar 31, 2025Mar 31, 2024
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate contracts 3, 4
$— $— $20 $— 
Excluded components 3, 5
(5)(38)— — 
Cash flow hedges:
Interest rate contracts 3
1 1 (1)(2)
Foreign currency contracts 6
(6)(13)2 1 
Commodity contracts 6
6 15 4 (8)
Excluded components 5, 6
— (6)(1)(1)
Net foreign investment hedges:
Foreign currency contracts(27)2 — — 
Excluded components 5, 7
27 6 7 3 
Total derivatives designated as hedging instruments$(4)$(33)$31 $(7)
Derivatives not designated as hedging instruments:
Foreign currency contracts 7
— — (56)31 
Commodity contracts 6
— — (5)8 
Total return swap 6
— — (11)22 
Total derivatives not designated as hedging instruments$— $— $(72)$61 
Total derivatives$(4)$(33)$(41)$54 
1.OCI is defined as other comprehensive income (loss).
2.Pretax amounts.
3.Included in "Interest expense and amortization of debt discount" in the consolidated statements of income.
4.Gain (loss) recognized in income of derivatives is offset by gain (loss) recognized in income of the hedged item.
5.The excluded components are related to the time value of the derivatives designated as hedges.
6.Included in "Cost of sales" in the consolidated statements of income.
7.Included in "Sundry income (expense) - net" in the consolidated statements of income.
Schedule of Hedging Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized Over Next Fiscal Year
The following table provides the net after-tax gain (loss) expected to be reclassified from AOCL to income within the next 12 months:

Expected Reclassifications from AOCL within the next 12 monthsMar 31, 2025
In millions
Cash flow hedges:
Interest rate contracts$(3)
Commodity contracts$13 
Foreign currency contracts$(1)
Excluded components$(3)
Net foreign investment hedges:
Excluded components$25 
v3.25.1
FAIR VALUE MEASUREMENTS (Tables)
 3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis:

Fair Value Measurements on a Recurring BasisMar 31, 2025Dec 31, 2024
In millionsFair Value LevelCostGainLossFair ValueCostGainLossFair Value
Assets at fair value:
Cash equivalents:
Held-to-maturity securities 1
Level 2$114 $— $— $114 $96 $— $— $96 
Money market fundsLevel 2567 — — 567 1,164 — — 1,164 
Marketable securities 2
Level 2393 — (53)340 453 — (70)383 
Other investments:
Debt securities: 3
Government debt 4
Level 21,107 13 (115)1,005 1,103 13 (123)993 
Corporate bondsLevel 118 — (1)17 18 — (1)17 
Corporate bondsLevel 2923 6 (85)844 954 6 (88)872 
Corporate bondsLevel 3200 — (35)165 200 — (49)151 
Equity securities 3, 5
Level 14 7 — 11 4 10 — 14 
Derivatives relating to: 6
Interest ratesLevel 2— 53 — 53 — 20 — 20 
Foreign currencyLevel 2— 81 — 81 — 107 — 107 
CommoditiesLevel 1— 8 — 8 — 4 — 4 
CommoditiesLevel 2— 108 — 108 — 87 — 87 
Total assets at fair value$3,313 $3,908 
Liabilities at fair value:
Long-term debt including debt due within one year 7
Level 2$(16,434)$1,520 $(462)$(15,376)$(16,208)$1,487 $(484)$(15,205)
Guarantee liability 8
Level 3(149)(155)
Derivatives relating to: 6
Interest ratesLevel 2— — (38)(38)— — (47)(47)
Foreign currencyLevel 2— — (328)(328)— — (142)(142)
CommoditiesLevel 1— — (2)(2)— — (1)(1)
CommoditiesLevel 2— — (80)(80)— — (64)(64)
Total liabilities at fair value$(15,973)$(15,614)
1.The Company's held-to-maturity securities primarily relate to treasury bills and time deposits. At March 31, 2025, $97 million is included in "Cash and cash equivalents" ($96 million at December 31, 2024) and $17 million is included in "Other current assets" (zero at December 31, 2024) in the consolidated balance sheets.
2.The Company’s investments in marketable securities are included in “Other current assets” in the consolidated balance sheets.
3.The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.
4.U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations.
5.Equity securities with a readily determinable fair value.
6.See Note 16 for classification of derivatives in the consolidated balance sheets.
7.Cost includes fair value hedge adjustment gains of $29 million at March 31, 2025 and $9 million at December 31, 2024 on $5,255 million of debt at March 31, 2025 and $5,129 million at December 31, 2024.
8.Estimated liability for TDCC's guarantee of Sadara's debt which is included in "Other noncurrent obligations" in the consolidated balance sheets.
v3.25.1
SEGMENTS AND GEOGRAPHIC REGIONS (Tables)
 3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Revenue from External Customers by Geographic Areas
Sales to external customers, which are attributed to geographic regions based on customer location, were as follows:

Sales to External Customers by Geographic RegionThree Months Ended
In millionsMar 31, 2025Mar 31, 2024
United States$3,946 $3,829 
EMEAI3,274 3,484 
Rest of World3,211 3,452 
Total$10,431 $10,765 
Long-Lived Assets by Geographic Areas
Long-lived assets, which are attributed to geographic regions based on asset location, were as follows:

Long-Lived Assets by Geographic RegionMar 31, 2025Dec 31, 2024
In millions
United States$15,176 $15,216 
EMEAI2,826 2,726 
Rest of World4,328 4,062 
Total$22,330 $22,004 
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Segment Operating EBIT 1
Pack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment Total
In millions
Three months ended Mar 31, 2025
Net sales$5,310 $2,855 $2,071 $10,236 
Cost of sales4,765 2,822 1,845 9,432 
SARD 2
240 127 151 518 
Equity in earnings (losses) of nonconsolidated affiliates39 (58)— (19)
Other segment income (expense) items 3
(2)24 (26)(4)
Segment Operating EBIT 4
$342 $(128)$49 $263 
Three months ended Mar 31, 2024
Net sales$5,430 $3,008 $2,152 $10,590 
Cost of sales4,597 2,776 1,894 9,267 
SARD 2
255 136 197 588 
Equity in earnings (losses) of nonconsolidated affiliates25 (15)6 16 
Other segment income (expense) items 3
2 6 (26)(18)
Segment Operating EBIT 4
$605 $87 $41 $733 
1.Significant expense categories are presented on an operating basis, net of the impact of significant items.
2.SARD includes selling, general and administrative and research and development expenses.
3.Other segment items includes amortization of intangibles and sundry income (expense) - net.
4.Segment Operating EBIT for TDCC for the three months ended March 31, 2025 and 2024 is substantially the same as that of Dow Inc. and therefore is not disclosed separately in the table above. A reconciliation of "Segment Operating EBIT" to "Income before income taxes" is provided in the following table.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated
Reconciliation of "Segment Operating EBIT" to "Income (Loss) Before Income Taxes"
Three Months Ended
In millionsMar 31, 2025Mar 31, 2024
Segment Operating EBIT$263 $733 
+ Corporate Operating EBIT(33)(59)
+ Interest income28 65 
- Interest expense and amortization of debt discount216 199 
+ Significant items(416)(91)
Income (loss) before income taxes$(374)$449 
Schedule of Other Segment Information [Table Text Block]
Other Segment InformationPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment Total
Corp. 1
Total
In millions
Three months ended Mar 31, 2025
Net sales$5,310 $2,855 $2,071 $10,236 $195 $10,431 
Depreciation and amortization$360 $146 $200 $706 $8 $714 
Capital expenditures$515 $129 $41 $685 $— $685 
Operating EBIT$342 $(128)$49 $263 $(33)$230 
Three months ended Mar 31, 2024
Net sales$5,430 $3,008 $2,152 $10,590 $175 $10,765 
Depreciation and amortization$371 $147 $193 $711 $9 $720 
Capital expenditures$469 $162 $83 $714 $— $714 
Operating EBIT$605 $87 $41 $733 $(59)$674 
1.Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. Net sales for Corporate are primarily related to insurance operations. Corporate expenses are primarily related to insurance operations, salaries and wages and non-business aligned environmental and legal costs.
Segment Asset Information
Segment Asset InformationPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment TotalCorp.Total
In millions
March 31, 2025
Total assets$28,966 $11,830 $11,370 $52,166 $5,333 $57,499 
Investments in nonconsolidated affiliates$740 $348 $142 $1,230 $45 $1,275 
December 31, 2024
Total assets$29,034 $11,928 $11,170 $52,132 $5,180 $57,312 
Investments in nonconsolidated affiliates$711 $367 $146 $1,224 $42 $1,266 
Schedule of significant items [Table Text Block]
The following tables summarize the pretax impact of significant items by segment excluded from Operating EBIT:

Significant Items by Segment
Three Months Ended Mar 31, 2025
Pack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment TotalCorp.Total
In millions
Restructuring, implementation and efficiency costs, and asset related charges - net 1
$— $(1)$— $(1)$(50)$(51)
2025 Restructuring Program 2
— — — — (207)(207)
Loss on early extinguishment of debt 3
— — — — (60)(60)
Indemnification and other transaction related costs 4
— — — — (98)(98)
Total$— $(1)$— $(1)$(415)$(416)
1.Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. Also includes impairment charges related to the write-down of certain manufacturing assets, partially offset by an asset related credit adjustment. See Note 4 for additional information.
2.Severance and related benefit costs associated with the Company's 2025 Restructuring Program. See Note 4 for additional information.
3.The Company retired outstanding long-term debt resulting in a loss on early extinguishment. See Note 9 for additional information.
4.Includes charges related to an arbitration settlement agreement for historical product claims from a divested business. See Note 10 for additional information.

Significant Items by Segment
Three Months Ended Mar 31, 2024
Pack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsOperating Segment TotalCorp.Total
In millions
Restructuring, implementation and efficiency costs, and asset related charges - net 1
$(37)$(8)$— $(45)$(46)$(91)
Total$(37)$(8)$— $(45)$(46)$(91)
1.Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. Also includes impairment charges related to the write-down of certain manufacturing assets.
v3.25.1
REVENUE (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Revenue from External Customer [Line Items]      
Revenue, Percentage from Products and Service Transferred to Customers 97.00% 98.00%  
Revenue, Remaining Performance Obligation, Amount $ 769   $ 759
Revenues 10,431 $ 10,765  
Contract with Customer, Liability, Revenue Recognized 80 40  
Accounts and notes receivable - Trade 4,917   4,756
Contract assets - noncurrent 0   2
Contract liabilities - current 207   244
Contract liabilities - noncurrent 1,459   1,480
The Dow Chemical Company      
Revenue from External Customer [Line Items]      
Accounts and notes receivable - Trade 4,917   $ 4,756
U.S. & Canada      
Revenue from External Customer [Line Items]      
Revenues 4,227 4,130  
EMEAI 1      
Revenue from External Customer [Line Items]      
Revenues 3,274 3,484  
Asia Pacific      
Revenue from External Customer [Line Items]      
Revenues 1,858 1,921  
Latin America      
Revenue from External Customer [Line Items]      
Revenues $ 1,072 1,230  
Maximum [Member]      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 19 years    
Packaging & Specialty Plastics [Member]      
Revenue from External Customer [Line Items]      
Revenues $ 5,310 5,430  
Packaging & Specialty Plastics [Member] | Hydrocarbons & Energy [Member]      
Revenue from External Customer [Line Items]      
Revenues 1,578 1,467  
Packaging & Specialty Plastics [Member] | Packaging and Specialty Plastics [Member]      
Revenue from External Customer [Line Items]      
Revenues 3,732 3,963  
Industrial Intermediates & Infrastructure [Member]      
Revenue from External Customer [Line Items]      
Revenues 2,855 3,008  
Industrial Intermediates & Infrastructure [Member] | Industrial Solutions [Member]      
Revenue from External Customer [Line Items]      
Revenues 1,054 1,028  
Industrial Intermediates & Infrastructure [Member] | Polyurethanes & CAV [Member]      
Revenue from External Customer [Line Items]      
Revenues 1,797 1,977  
Industrial Intermediates & Infrastructure [Member] | Other [Member]      
Revenue from External Customer [Line Items]      
Revenues 4 3  
Performance Materials & Coatings [Member]      
Revenue from External Customer [Line Items]      
Revenues 2,071 2,152  
Performance Materials & Coatings [Member] | Coatings and Performance Monomers [Member]      
Revenue from External Customer [Line Items]      
Revenues 845 885  
Performance Materials & Coatings [Member] | Consumer Solutions [Member]      
Revenue from External Customer [Line Items]      
Revenues 1,226 1,267  
Corporate Segment [Member]      
Revenue from External Customer [Line Items]      
Revenues $ 195 $ 175  
v3.25.1
RESTRUCTURING AND ASSET RELATED CHARGES - NET (2023 Restructuring Program) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Restructuring Cost and Reserve [Line Items]    
Restructuring and asset related charges - net $ (208) $ (45)
2023 Restructuring Program | Restructuring Implementation Costs    
Restructuring Cost and Reserve [Line Items]    
Payments for Restructuring 50 $ 46
Industrial Intermediates & Infrastructure [Member] | 2023 Restructuring Program | Asset write-downs and write-offs [Member]    
Restructuring Cost and Reserve [Line Items]    
Restructuring and asset related charges - net (5)  
Industrial Intermediates & Infrastructure [Member] | 2023 Restructuring Program | Asset related credit adjustment    
Restructuring Cost and Reserve [Line Items]    
Restructuring and asset related charges - net $ (4)  
v3.25.1
Restructuring and related activities (2025 Restructuring Program) (Details)
 3 Months Ended
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Mar. 31, 2024
USD ($)
Restructuring Cost and Reserve [Line Items]      
Restructuring and asset related charges - net   $ 208,000,000 $ 45,000,000
2025 Program      
Restructuring Cost and Reserve [Line Items]      
Restructuring and related workforce reduction   1,500  
Restructuring Reserve   $ 207,000,000  
2025 Program | Maximum [Member] | Subsequent Event      
Restructuring Cost and Reserve [Line Items]      
Book Value of Assets Under Operational Review $ 275,000,000    
2025 Program | Accrued and Other Current Liabilities [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve   167,000,000  
2025 Program | Other Noncurrent Obligations [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve   40,000,000  
2025 Program | Restructuring Implementation Costs | Additional Cash Expenditures      
Restructuring Cost and Reserve [Line Items]      
Restructuring and Related Cost, Expected Cost   10,000,000  
Segment Reporting, Reconciling Item, Corporate Nonsegment | 2025 Program | Employee Severance [Member]      
Restructuring Cost and Reserve [Line Items]      
Restructuring and asset related charges - net   $ 207,000,000  
v3.25.1
Summary of Sundry Income (Expense) - Net (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Gain (Loss) on Extinguishment of Debt $ 60  
Other Nonoperating Income (Expense) 31 $ 14
Sundry income (expense) - net 13 61
Nonoperating Income (Expense)    
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) 38 61
Foreign Currency Transaction Gain (Loss), before Tax 7 (23)
Gain (Loss) on Disposition of Other Assets (3) 9
Gain (Loss) on Extinguishment of Debt $ (60) $ 0
v3.25.1
Company-Owned Life Insurance (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Gross Life Insurance, Corporate or Bank Owned, Amount $ 544 $ 558
Life Insurance, Corporate or Bank Owned, Amount 344 558
COLI Monetization [Member]    
Other Short-term Borrowings $ 200 $ 0
v3.25.1
Supplier Finance Program (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Minimum [Member]    
Supplier Finance Program, Payment Timing, Period 90 days  
Maximum [Member]    
Supplier Finance Program, Payment Timing, Period 120 days  
Accounts Payable    
Supplier Finance Program Obligation, Current $ 285 $ 291
v3.25.1
EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Net income (loss) $ (290) $ 538
Net income attributable to noncontrolling interests 17 22
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic 3 3
Net Income (Loss) Available to Common Stockholders, Basic $ (310) $ 513
Earnings Per Share, Basic $ (0.44) $ 0.73
Earnings Per Share, Diluted $ (0.44) $ 0.73
Weighted-average common shares outstanding - basic 706.9 704.5
Dilutive effect of equity compensation plans 0.0 1.0
Weighted-average common shares outstanding - diluted 706.9 705.5
Stock options and restricted stock units excluded from EPS calculations 14.9 8.8
v3.25.1
INVENTORIES (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Inventory Disclosure [Abstract]    
Finished goods $ 3,947 $ 3,773
Work in process 1,368 1,323
Raw materials 847 822
Supplies 1,084 1,039
Total 7,246 6,957
Adjustment of inventories to the LIFO basis (481) (413)
Total inventories $ 6,765 $ 6,544
v3.25.1
TRANSFERS OF FINANCIAL ASSETS (Details)
€ in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2025
USD ($)
Mar. 31, 2024
USD ($)
Mar. 31, 2025
EUR (€)
Dec. 31, 2024
USD ($)
Cash Flows Between Transferor and Transferee, Proceeds from New Transfers $ 514 $ 427    
Balance Outstanding Related to Transfers of Accounts Receivable 535     $ 287
Transfer of Financial Assets Accounted for as Sales, Amount Derecognized 511     278
Transfers of Accounts Receivable, Amounts Recognized in the Balance Sheet Not Remitted 24     $ 9
Accounts Receivable Facility, U.S.        
Trade Accounts Receivable Eligible for Sale $ 900      
Accounts Receivable Facility, Europe [Member]        
Trade Accounts Receivable Eligible for Sale | €     € 500  
v3.25.1
NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES Notes Payable (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Short-term Debt [Line Items]    
Period-end average interest rates 28.93% 36.03%
Notes Payable to Banks [Member]    
Short-term Debt [Line Items]    
Short-term Debt $ 136 $ 135
v3.25.1
NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES Long-Term Debt (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Debt Instrument [Line Items]    
Unamortized debt discount and issuance costs $ (225) $ (244)
Long-term debt due within one year 3 (502) (497)
Long-Term Debt 15,932 15,711
Long Term Debt, Accumulated Fair Value Adjustment 29 $ 9
Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year 472  
Long-Term Debt, Maturity, Year One 149  
Long-term Debt, Maturities, Repayments of Principal in Year Two 746  
Long-term Debt, Maturities, Repayments of Principal in Year Three 702  
Long-term Debt, Maturities, Repayments of Principal in Year Four 1,045  
Long-term Debt, Maturities, Repayments of Principal in Year Five 911  
Gain (Loss) on Extinguishment of Debt (60)  
Senior Unsecured Notes    
Debt Instrument [Line Items]    
Debt Instrument, Face Amount 1,000  
InterNotes    
Debt Instrument [Line Items]    
Notes Issued $ 13  
Senior Unsecured Notes, 5.35 Percent, Due 2035    
Debt Instrument [Line Items]    
Debt Instrument, Interest Rate, Stated Percentage 5.35%  
Debt Instrument, Face Amount $ 400  
Senior Unsecured Notes, 5.95 Percent, Due 2055    
Debt Instrument [Line Items]    
Debt Instrument, Interest Rate, Stated Percentage 5.95%  
Debt Instrument, Face Amount $ 600  
Debt Securities [Member]    
Debt Instrument [Line Items]    
Repayments of Debt 943  
Debt Securities [Member] | Sundry Income (Expense), Net [Member]    
Debt Instrument [Line Items]    
Gain (Loss) on Extinguishment of Debt $ 60  
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year One [Member]    
Debt Instrument [Line Items]    
Long-term Debt, Weighted Average Interest Rate, at Point in Time 5.63% 5.63%
Long-term Debt, Gross $ 333 $ 333
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year Four [Member]    
Debt Instrument [Line Items]    
Long-term Debt, Weighted Average Interest Rate, at Point in Time 4.80% 4.80%
Long-term Debt, Gross $ 600 $ 600
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year Five [Member]    
Debt Instrument [Line Items]    
Long-term Debt, Weighted Average Interest Rate, at Point in Time 7.53% 7.58%
Long-term Debt, Gross $ 951 $ 1,368
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year Six    
Debt Instrument [Line Items]    
Long-term Debt, Weighted Average Interest Rate, at Point in Time 2.10% 2.10%
Long-term Debt, Gross $ 818 $ 818
Loans Payable [Member] | Promissory Notes and Debentures, Final Maturity, Year Seven and Thereafter    
Debt Instrument [Line Items]    
Long-term Debt, Weighted Average Interest Rate, at Point in Time 5.41% 5.37%
Long-term Debt, Gross $ 10,209 $ 9,192
Loans Payable [Member] | Foreign Currency Loans [Member]    
Debt Instrument [Line Items]    
Long-term Debt, Weighted Average Interest Rate, at Point in Time 2.18% 2.01%
Long-term Debt, Gross $ 2,094 $ 2,540
InterNotes    
Debt Instrument [Line Items]    
Long-term Debt, Weighted Average Interest Rate, at Point in Time 4.34% 4.31%
Long-term Debt, Gross $ 668 $ 661
Medium-term Notes [Member]    
Debt Instrument [Line Items]    
Long-term Debt, Weighted Average Interest Rate, at Point in Time 4.75% 4.75%
Long-term Debt, Gross $ 1 $ 1
Finance Leases [Member]    
Debt Instrument [Line Items]    
Finance lease obligations 2 $ 985 $ 939
v3.25.1
NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES Committed and Available Credit Facilities (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2025
USD ($)
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity $ 8,400
Line of Credit Facility, Remaining Borrowing Capacity 8,400
Debt Securities [Member]  
Line of Credit Facility [Line Items]  
Repayments of Debt 943
Revolving Credit Facility [Member] | Five Year Competitive Advance and Revolving Credit Facility [Member]  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 5,000
Line of Credit Facility, Remaining Borrowing Capacity 5,000
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due March 2025, Facility One [Member]  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 100
Line of Credit Facility, Remaining Borrowing Capacity 100
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due March 2025, Facility Two [Member]  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 100
Line of Credit Facility, Remaining Borrowing Capacity 100
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due September 2025  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 200
Line of Credit Facility, Remaining Borrowing Capacity 200
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due March 2026  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 100
Line of Credit Facility, Remaining Borrowing Capacity 100
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due November 2026  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 150
Line of Credit Facility, Remaining Borrowing Capacity 150
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due May 2027  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 100
Line of Credit Facility, Remaining Borrowing Capacity 100
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due June 2027  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 350
Line of Credit Facility, Remaining Borrowing Capacity 350
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due September 2027  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 200
Line of Credit Facility, Remaining Borrowing Capacity 200
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due September 2025, Facility Two  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 175
Line of Credit Facility, Remaining Borrowing Capacity 175
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due November 2025  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 300
Line of Credit Facility, Remaining Borrowing Capacity 300
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due November 2026, Facility Two  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 200
Line of Credit Facility, Remaining Borrowing Capacity 200
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due March 2027  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 250
Line of Credit Facility, Remaining Borrowing Capacity 250
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due October 2027  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 100
Line of Credit Facility, Remaining Borrowing Capacity 100
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due November 2027  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 100
Line of Credit Facility, Remaining Borrowing Capacity 100
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due Due May 2028  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 300
Line of Credit Facility, Remaining Borrowing Capacity 300
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due October 2024  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 375
Line of Credit Facility, Remaining Borrowing Capacity 375
Revolving Credit Facility [Member] | Bilateral Revolving Credit Facility, Due February 2026  
Line of Credit Facility [Line Items]  
Line of Credit Facility, Maximum Borrowing Capacity 300
Line of Credit Facility, Remaining Borrowing Capacity $ 300
v3.25.1
COMMITMENTS AND CONTINGENCIES (Environmental Matters) (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Loss Contingencies [Line Items]    
Accrual for environmental loss contingencies $ 1,072 $ 1,113
Accrual For Environmental Loss Contingencies Superfund Sites [Member]    
Loss Contingencies [Line Items]    
Accrual for environmental loss contingencies $ 227 $ 234
v3.25.1
COMMITMENTS AND CONTINGENCIES (Asbestos-Related Matters of Union Carbide Corporation) (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Loss Contingencies [Line Items]    
Liability for Asbestos and Environmental Claims, Gross $ 767 $ 791
Percentage of recorded asbestos liability related to pending claims 25.00%  
Percentage of recorded asbestos liability related to future claims 75.00%  
v3.25.1
Commitment and Contingencies (Legacy Matters) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Legacy agricultural chemical prodcuts      
Product Liability Contingency [Line Items]      
Product Liability Accrual, Component Amount $ 155   $ 155
Legacy historical product claims - arbitration      
Product Liability Contingency [Line Items]      
Product Liability Accrual, Period Expense   $ 75  
Product Liability Accrual, Component Amount 98    
Legacy historical product claims - arbitration | Segment Reporting, Reconciling Item, Corporate Nonsegment      
Product Liability Contingency [Line Items]      
Product Liability Accrual, Period Expense $ 98    
v3.25.1
COMMITMENTS AND CONTINGENCIES Nova Ethylene Asset Matter (Details) - Nova Ethylene Asset Matter [Member]
$ in Millions, $ in Millions
 3 Months Ended
Sep. 18, 2019
CAD ($)
Sep. 18, 2019
USD ($)
Mar. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Gain Contingencies [Line Items]        
Litigation Settlement, Amount Awarded from Other Party $ 1,430 $ 1,080 $ 1,000  
Estimated Litigation Liability, Noncurrent     $ 201 $ 201
v3.25.1
COMMITMENTS AND CONTINGENCIES (Guarantees) (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Sadara Chemical Company [Member]    
Guarantor Obligations [Line Items]    
Equity Method Investment, Ownership Percentage 35.00%  
Performance Guarantee [Member]    
Guarantor Obligations [Line Items]    
Guarantor obligations, maximum future payments $ 1,661 $ 1,456
Guarantor obligations, recorded liability 150 155
Performance Guarantee [Member] | Sadara Chemical Company [Member]    
Guarantor Obligations [Line Items]    
Guarantor obligations, maximum future payments 1,300  
Performance Guarantee [Member] | Sadara Chemical Company [Member] | Sadara Chemical Company [Member]    
Guarantor Obligations [Line Items]    
Guarantor obligations, maximum future payments 500  
Accounts Receivable Facilities Performance    
Guarantor Obligations [Line Items]    
Guarantor obligations, maximum future payments $ 444 $ 239
v3.25.1
LEASES COSTS AND OTHER INFORMATION (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Leases [Abstract]    
Operating Lease, Cost $ 106 $ 107
Finance Lease, Right-of-Use Asset, Amortization 32 27
Finance Lease, Interest Expense 12 10
Finance Lease, Cost 44 37
Short-term Lease, Cost 80 74
Variable Lease, Cost 255 258
Sublease Income (2) (2)
Lease, Cost 483 474
Operating Lease, Payments 112 116
Finance Lease, Interest Payment on Liability 12 10
Finance Lease, Principal Payments 29 30
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 110 100
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability $ 65 $ 70
v3.25.1
Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Other Comprehensive Income (Loss), Net of Tax $ 154 $ (133)    
Derivative instruments (20) (22)    
Total equity 17,295 18,917 $ 17,851  
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Other Comprehensive Income (Loss), before Reclassifications, before Tax 40 15    
Other Comprehensive Income (Loss), Tax (7) (18)    
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 33 (3)    
Other Comprehensive Income (Loss), Net of Tax 32 (6)    
Total equity (211) (259) (243) $ (253)
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax (1) (4)    
Reclassification from AOCI, Current Period, Tax 0 1    
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax (1) (3)    
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Other Comprehensive Income (Loss), before Reclassifications, before Tax 126 (116)    
Other Comprehensive Income (Loss), Tax 3 (3)    
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 129 (119)    
Other Comprehensive Income (Loss), Net of Tax 122 (122)    
Total equity (1,941) (2,013) (2,063) (1,891)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax (7) (3)    
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Other Comprehensive Income (Loss), before Reclassifications, before Tax 0 (1)    
Other Comprehensive Income (Loss), Net of Tax 20 17    
Total equity (5,700) (5,469) (5,720) (5,486)
Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 26 22    
Reclassification from AOCI, Current Period, Tax (6) (4)    
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax 20 18    
Accumulated Other Comprehensive Loss        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Other Comprehensive Income (Loss), Net of Tax 154 (133)    
Total equity (7,956) (7,814) (8,110) (7,681)
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Other Comprehensive Income (Loss), before Reclassifications, before Tax (15) (33)    
Other Comprehensive Income (Loss), Tax (2) 3    
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax (17) (30)    
Derivative instruments (20) (22)    
Total equity (104) (73) $ (84) $ (51)
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent | Reclassification out of Accumulated Other Comprehensive Income [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax (4) 10    
Reclassification from AOCI, Current Period, Tax 1 (2)    
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax $ (3) $ 8    
v3.25.1
NONCONTROLLING INTERESTS Noncontrolling Interests (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Noncontrolling Interest [Line Items]        
Total equity $ 17,295 $ 18,917 $ 17,851  
Noncontrolling Interest [Member]        
Noncontrolling Interest [Line Items]        
Total equity 507 492 $ 496 $ 501
Net income attributable to noncontrolling interests 17 22    
Distributions to noncontrolling interests (22) (14)    
Cumulative translation adjustments 16 (16)    
Other $ 0 $ (1)    
v3.25.1
PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Pension Plan [Member]    
Defined Benefit Plan Disclosures [Line Items]    
Service cost $ 10 $ 14
Interest cost 246 252
Expected return on plan assets 319 346
Amortization of prior service credit (3) (3)
Defined Benefit Plan, Amortization of (Gain) Loss 40 35
Net periodic benefit cost (26) (48)
Other Postretirement Benefits [Member]    
Defined Benefit Plan Disclosures [Line Items]    
Service cost 1 1
Interest cost 9 11
Defined Benefit Plan, Amortization of (Gain) Loss (11) (10)
Net periodic benefit cost $ (1) $ 2
v3.25.1
STOCK-BASED COMPENSATION (Stock Incentive Plan) (Details)
shares in Thousands
 3 Months Ended
Mar. 31, 2025
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares 1,800
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares $ 38.34
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 8.27
Employee Stock Purchase Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate 10.00%
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent 85.00%
Employee Stock Purchase Plan | Employee  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Right to purchase shares subscribed by employees | shares 3,200
Restricted Stock Units (RSUs) [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares 3,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 38.34
Performance Stock Units (PSUs) [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares 2,100
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 38.46
v3.25.1
Debt Investments (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Debt Securities, Available-for-sale [Line Items]      
Proceeds from sales of available-for-sale securities $ 154 $ 721  
Gross realized gains 2 9  
Available-for-sale Securities, Gross Realized Losses (1) (5)  
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost 110    
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value 100    
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost 1,188    
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value 1,094    
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Amortized Cost 426    
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Fair Value 412    
Debt Securities, Available-for-sale, Allocated and Single Maturity Date, Maturity, after 10 Years, Amortized Cost 524    
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after 10 Years, Fair Value 425    
Debt Securities, Available-for-sale, Amortized Cost 2,248    
Debt Securities, Available-for-sale 2,031    
Equity Securities, Net Unrealized Gain (Loss) 3 $ 0  
Equity Securities, FV-NI, Current 11   $ 14
Equity Securities without Readily Determinable Fair Value, Amount $ 149   $ 153
v3.25.1
Notional Amounts (Details)
$ in Millions
Mar. 31, 2025
USD ($)
Boe
Dec. 31, 2024
USD ($)
Boe
Interest Rate Swap [Member] | Designated as Hedging Instrument [Member]    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Derivative, Notional Amount $ 757 $ 1,870
Interest Rate Swap [Member] | Not Designated as Hedging Instrument [Member]    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Derivative, Notional Amount 44 14
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Derivative, Notional Amount 4,080 3,144
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Derivative, Notional Amount $ 19,738 $ 9,244
Commodity Contract Hydrocarbons | Designated as Hedging Instrument [Member]    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Derivative, Nonmonetary Notional Amount | Boe 5,000,000.0 3,200,000
Commodity Contract Hydrocarbons | Not Designated as Hedging Instrument [Member]    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Derivative, Nonmonetary Notional Amount | Boe 1,000,000.0 1,100,000
v3.25.1
Schedule of Fair Value of Derivative Instruments (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement $ 250 $ 218
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset (182) (105)
Derivative Asset 68 113
Derivative Liability, Fair Value, Gross Liability 448 254
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset (183) (105)
Derivative Liability 265 149
Derivative Liability, Collateral, Right to Reclaim Cash, Offset 12 16
Derivative Asset, Collateral, Obligation to Return Cash, Offset 0 0
Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 207 124
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset (153) (85)
Derivative Asset 54 39
Derivative Liability, Fair Value, Gross Liability 262 214
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset (154) (85)
Derivative Liability 108 129
Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 43 94
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset (29) (20)
Derivative Asset 14 74
Derivative Liability, Fair Value, Gross Liability 186 40
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset (29) (20)
Derivative Liability 157 20
Interest Rate Contract [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Current 0 26
Derivative Asset, Noncurrent (6) 0
Derivative Liability, Noncurrent 0 0
Derivative Asset, Current 9 0
Interest Rate Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Current 0 1
Derivative Asset, Noncurrent 0 0
Derivative Liability, Noncurrent 0 0
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Current 64 60
Derivative Asset, Noncurrent (1) 0
Derivative Liability, Noncurrent 32 40
Derivative Asset, Current 1 18
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Current 154 11
Derivative Asset, Current 1 58
Commodity Contract [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Current 10 2
Derivative Asset, Noncurrent (7) (10)
Derivative Liability, Noncurrent 2 1
Derivative Asset, Current 30 11
Commodity Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Current 3 7
Derivative Asset, Noncurrent (1) (1)
Derivative Liability, Noncurrent 0 1
Derivative Asset, Current 12 15
Other Current Assets [Member] | Interest Rate Contract [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 27 20
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset (18) (20)
Other Current Assets [Member] | Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 34 33
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset (33) (15)
Other Current Assets [Member] | Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 25 74
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset (24) (16)
Other Current Assets [Member] | Commodity Contract [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 55 25
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset (25) (14)
Other Current Assets [Member] | Commodity Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 13 16
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset (1) (1)
Deferred charges and other assets [Member] | Interest Rate Contract [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 25 0
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset (19) 0
Deferred charges and other assets [Member] | Interest Rate Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 1 0
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset (1) 0
Deferred charges and other assets [Member] | Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 22 0
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset (21) 0
Deferred charges and other assets [Member] | Commodity Contract [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 44 46
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset (37) (36)
Deferred charges and other assets [Member] | Commodity Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 4 4
Derivative Asset, Fair Value, Gross Liability and Obligation to Return Cash, Offset (3) (3)
Accrued and Other Current Liabilities [Member] | Interest Rate Contract [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value, Gross Liability 18 46
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset (18) (20)
Accrued and Other Current Liabilities [Member] | Interest Rate Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value, Gross Liability 0 1
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset 0 0
Accrued and Other Current Liabilities [Member] | Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value, Gross Liability 97 75
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset (33) (15)
Accrued and Other Current Liabilities [Member] | Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value, Gross Liability 178 27
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset (24) (16)
Accrued and Other Current Liabilities [Member] | Commodity Contract [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value, Gross Liability 36 16
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset (26) (14)
Accrued and Other Current Liabilities [Member] | Commodity Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value, Gross Liability 4 8
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset (1) (1)
Other Noncurrent Obligations [Member] | Interest Rate Contract [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value, Gross Liability 19 0
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset (19) 0
Other Noncurrent Obligations [Member] | Interest Rate Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value, Gross Liability 1 0
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset (1) 0
Other Noncurrent Obligations [Member] | Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value, Gross Liability 53 40
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset (21) 0
Other Noncurrent Obligations [Member] | Commodity Contract [Member] | Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value, Gross Liability 39 37
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset (37) (36)
Other Noncurrent Obligations [Member] | Commodity Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value, Gross Liability 3 4
Derivative Liability, Fair Value, Gross Asset and Right to Reclaim Cash, Offset $ (3) $ (3)
v3.25.1
Effect of Derivative Instruments (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Derivative Instruments, Gain (Loss) [Line Items]    
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax $ (20) $ (22)
Designated as Hedging Instrument [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (Loss) on Hedging Activity 31 (7)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax (4) (33)
Not Designated as Hedging Instrument [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net (72) 61
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 0 0
Interest Rate Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 1 1
Interest Rate Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Expense and Amortization of Debt Discount    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (Loss) on Hedging Activity (1) (2)
Interest Rate Contract [Member] | Fair Value Hedging [Member] | Designated as Hedging Instrument [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 0 0
Interest Rate Contract [Member] | Fair Value Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Expense and Amortization of Debt Discount    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (Loss) on Hedging Activity 20 0
Excluded Components [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Cumulative Translation Adjustments [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 0 (6)
Excluded Components [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Cost of Sales    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (Loss) from Components Excluded from Assessment of Cash Flow Hedge Effectiveness, Net (1) (1)
Excluded Components [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Cumulative Translation Adjustments [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 27 6
Excluded Components [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Other Nonoperating Income (Expense) [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax 7 3
Excluded Components [Member] | Fair Value Hedging [Member] | Designated as Hedging Instrument [Member] | Cumulative Translation Adjustments [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax (5) (38)
Excluded Components [Member] | Fair Value Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Expense and Amortization of Debt Discount    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net 0 0
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 0 0
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | Other Nonoperating Income (Expense) [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net (56) 31
Foreign Exchange Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax (6) (13)
Foreign Exchange Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Cost of Sales    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (Loss) on Hedging Activity 2 1
Foreign Exchange Contract [Member] | Net Investment Hedging [Member] | Designated as Hedging Instrument [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (Loss) on Hedging Activity 0 0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax (27) 2
Commodity Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 0 0
Commodity Contract [Member] | Not Designated as Hedging Instrument [Member] | Cost of Sales    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net (5) 8
Commodity Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 6 15
Commodity Contract [Member] | Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Cost of Sales    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (Loss) on Hedging Activity 4 (8)
Derivative    
Derivative Instruments, Gain (Loss) [Line Items]    
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax (4) (33)
Derivative, Gain (Loss) on Derivative, Net (41) 54
Total Return Swap | Not Designated as Hedging Instrument [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 0 0
Total Return Swap | Not Designated as Hedging Instrument [Member] | Cost of Sales    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net $ (11) $ 22
v3.25.1
Expected Reclassification (Details)
$ in Millions
Mar. 31, 2025
USD ($)
Interest Rate Contract [Member]  
Derivative Instruments and Hedging Activities Disclosures [Line Items]  
Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net $ (3)
Commodity Contract [Member]  
Derivative Instruments and Hedging Activities Disclosures [Line Items]  
Price Risk Cash Flow Hedge Unrealized Gain (Loss) to be Reclassified During Next 12 Months 13
Foreign Exchange Contract [Member]  
Derivative Instruments and Hedging Activities Disclosures [Line Items]  
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months (1)
Excluded Components [Member]  
Derivative Instruments and Hedging Activities Disclosures [Line Items]  
Hedge Gain (Loss) to be Reclassified During Next 12 Months, Excluded Components, Net (3)
Excluded Components [Member] | Net Investment Hedging [Member]  
Derivative Instruments and Hedging Activities Disclosures [Line Items]  
Hedge Gain (Loss) to be Reclassified During Next 12 Months, Excluded Components, Net $ 25
v3.25.1
FAIR VALUE MEASUREMENTS (Summary of Recurring Measured Fair Values) (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale $ 2,031  
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 250 $ 218
Debt Securities, Available-for-sale, Amortized Cost 2,248  
Equity Securities, FV-NI, Current 11 14
Long-term Debt   (16,208)
Long Term Debt, Accumulated Gross Unrealized Gain, Before Tax   1,487
Long Term Debt, Accumulated Gross Unrealized Loss, Before Tax   (484)
Long Term Debt, Accumulated Fair Value Adjustment 29 9
Derivative, Amount of Hedged Item 5,255 5,129
Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Equity Securities, Amortized Cost Basis 4 4
Equity Securities, Accumulated Gross Unrealized Gain, Before Tax 7 10
Equity Securities, Accumulated Gross Unrealized Loss, Before Tax 0 0
Fair Value, Inputs, Level 1 [Member] | Commodity Contract [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Liabilities, Accumulated Gross Unrealized Gain, Before Tax 0 0
Derivative Liabilities, Accumulated Gross Unrealized Loss, Before Tax (2) (1)
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax 8 4
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax 0 0
Fair Value, Inputs, Level 1 [Member] | Corporate Debt Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 18 18
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax 0 0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax (1) (1)
Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Long-term Debt (16,434) (16,208)
Long Term Debt, Accumulated Gross Unrealized Gain, Before Tax 1,520 1,487
Long Term Debt, Accumulated Gross Unrealized Loss, Before Tax (462) (484)
Available-for-sale Debt Securities, Amortized Cost Basis, Current 393 453
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, Current, before Tax 0 0
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, Current, before Tax (53) (70)
Fair Value, Inputs, Level 2 [Member] | Held-to-maturity Securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash Equivalents, at Carrying Value 114 96
Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax 0 0
Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax 0 0
Fair Value, Inputs, Level 2 [Member] | Money Market Funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash Equivalents, at Carrying Value 567 1,164
Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax 0 0
Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax 0 0
Fair Value, Inputs, Level 2 [Member] | Interest Rate Swap [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Liabilities, Accumulated Gross Unrealized Gain, Before Tax 0 0
Derivative Liabilities, Accumulated Gross Unrealized Loss, Before Tax (38) (47)
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax 53 20
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax 0 0
Fair Value, Inputs, Level 2 [Member] | Foreign Exchange Contract [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Liabilities, Accumulated Gross Unrealized Gain, Before Tax 0 0
Derivative Liabilities, Accumulated Gross Unrealized Loss, Before Tax (328) (142)
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax 81 107
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax 0 0
Fair Value, Inputs, Level 2 [Member] | Commodity Contract [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Liabilities, Accumulated Gross Unrealized Gain, Before Tax 0 0
Derivative Liabilities, Accumulated Gross Unrealized Loss, Before Tax (80) (64)
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax 108 87
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax 0 0
Fair Value, Inputs, Level 2 [Member] | US Treasury and Government [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 1,107 1,103
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax 13 13
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax (115) (123)
Fair Value, Inputs, Level 2 [Member] | Corporate Debt Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 923 954
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax 6 6
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax (85) (88)
Fair Value, Inputs, Level 3 [Member] | Corporate Debt Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale, Amortized Cost 200 200
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax 0 0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax (35) (49)
Fair Value, Recurring [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets at fair value 3,313 3,908
Total liabilities at fair value (15,973) (15,614)
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Equity Securities, FV-NI, Current 11 14
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Commodity Contract [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 8 4
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement (2) (1)
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Corporate Debt Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 17 17
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale, Current 340 383
Long-term debt including debt due within one year 6 15,376 15,205
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Held-to-maturity Securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash Equivalents, Fair Value 114 96
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Held-to-maturity Securities | Cash and cash equivalents    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash Equivalents, Fair Value 97 96
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Held-to-maturity Securities | Other Current Assets [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash Equivalents, Fair Value 17 0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Money Market Funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash Equivalents, Fair Value 567 1,164
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Interest Rate Swap [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 53 20
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement (38) (47)
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Foreign Exchange Contract [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 81 107
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement (328) (142)
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Commodity Contract [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement 108 87
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement (80) (64)
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | US Treasury and Government [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 1,005 993
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Corporate Debt Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale 844 872
Fair Value, Recurring [Member] | Fair Value Measured at Net Asset Value Per Share [Member] | Private Market Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets at fair value 87 90
Fair Value, Recurring [Member] | Fair Value Measured at Net Asset Value Per Share [Member] | Real Estate [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets at fair value 14 15
Fair Value, Recurring [Member] | Fair Value Measured at Net Asset Value Per Share [Member] | Private Market Securities and Real Estate [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments 80 81
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Sadara Chemical Company [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Guarantees, Fair Value Disclosure (149) (155)
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Corporate Debt Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale $ 165 $ 151
v3.25.1
FAIR VALUE MEASUREMENTS (Summary of Nonrecurring Measured Fair Values) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Restructuring and asset related charges - net $ 208 $ 45
Asset write-downs and write-offs [Member] | 2023 Restructuring Program | Industrial Intermediates & Infrastructure [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Restructuring and asset related charges - net $ 5  
v3.25.1
SEGMENTS AND GEOGRAPHIC REGIONS Geographic Region Information (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales $ 10,431 $ 10,765  
Net property 22,330   $ 22,004
UNITED STATES      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 3,946 3,829  
Net property 15,176   15,216
Europe, Middle East, Africa and India [Domain]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 3,274 3,484  
Net property 2,826   2,726
Rest of World [Domain]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Net sales 3,211 $ 3,452  
Net property $ 4,328   $ 4,062
v3.25.1
SEGMENTS AND GEOGRAPHIC REGIONS Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Net sales $ 10,431 $ 10,765
Equity in earnings (losses) of nonconsolidated affiliates (20) 17
Operating EBIT 230 674
Segment Reporting, Reconciling Item, Corporate Nonsegment    
Segment Reporting Information [Line Items]    
Net sales 195 175
Operating EBIT (33) (59)
Operating Segment Total    
Segment Reporting Information [Line Items]    
Net sales 10,236 10,590
Operating Cost of Goods and Services Sold 9,432 9,267
SARD 518 588
Equity in earnings (losses) of nonconsolidated affiliates (19) 16
Segment Reporting, Other Segment Item, Amount (4) (18)
Operating EBIT 263 733
Packaging & Specialty Plastics [Member] | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 5,310 5,430
Operating Cost of Goods and Services Sold 4,765 4,597
SARD 240 255
Equity in earnings (losses) of nonconsolidated affiliates 39 25
Segment Reporting, Other Segment Item, Amount (2) 2
Operating EBIT 342 605
Industrial Intermediates & Infrastructure [Member] | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 2,855 3,008
Operating Cost of Goods and Services Sold 2,822 2,776
SARD 127 136
Equity in earnings (losses) of nonconsolidated affiliates (58) (15)
Segment Reporting, Other Segment Item, Amount 24 6
Operating EBIT (128) 87
Performance Materials & Coatings [Member] | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 2,071 2,152
Operating Cost of Goods and Services Sold 1,845 1,894
SARD 151 197
Equity in earnings (losses) of nonconsolidated affiliates 0 6
Segment Reporting, Other Segment Item, Amount (26) (26)
Operating EBIT $ 49 $ 41
v3.25.1
SEGMENTS AND GEOGRAPHIC REGIONS EBIT Reconciliation (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Operating EBIT $ 230 $ 674
Interest Income, Other 28 65
Interest Expense, Debt 216 199
Other Nonrecurring (Income) Expense (416) (91)
Income before income taxes (374) 449
Operating Segment Total    
Segment Reporting Information [Line Items]    
Operating EBIT 263 733
Other Nonrecurring (Income) Expense (1) (45)
Packaging & Specialty Plastics [Member] | Operating Segments    
Segment Reporting Information [Line Items]    
Operating EBIT 342 605
Other Nonrecurring (Income) Expense 0 (37)
Industrial Intermediates & Infrastructure [Member] | Operating Segments    
Segment Reporting Information [Line Items]    
Operating EBIT (128) 87
Other Nonrecurring (Income) Expense (1) (8)
Performance Materials & Coatings [Member] | Operating Segments    
Segment Reporting Information [Line Items]    
Operating EBIT 49 41
Other Nonrecurring (Income) Expense $ 0 $ 0
v3.25.1
SEGMENT AND GEOGRAPHIC REGIONS Other Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Net sales $ 10,431 $ 10,765
Depreciation and amortization 714 720
Payments to Acquire Productive Assets 685 714
Operating EBIT 230 674
Segment Reporting, Reconciling Item, Corporate Nonsegment    
Segment Reporting Information [Line Items]    
Net sales 195 175
Depreciation and amortization 8 9
Payments to Acquire Productive Assets 0 0
Operating EBIT (33) (59)
Operating Segment Total    
Segment Reporting Information [Line Items]    
Net sales 10,236 10,590
Depreciation and amortization 706 711
Payments to Acquire Productive Assets 685 714
Operating EBIT 263 733
Packaging & Specialty Plastics [Member] | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 5,310 5,430
Depreciation and amortization 360 371
Payments to Acquire Productive Assets 515 469
Operating EBIT 342 605
Industrial Intermediates & Infrastructure [Member] | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 2,855 3,008
Depreciation and amortization 146 147
Payments to Acquire Productive Assets 129 162
Operating EBIT (128) 87
Performance Materials & Coatings [Member] | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 2,071 2,152
Depreciation and amortization 200 193
Payments to Acquire Productive Assets 41 83
Operating EBIT $ 49 $ 41
v3.25.1
SEGMENTS AND GEOGRAPHIC REGIONS Segment Asset Information (Details) - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Segment Reporting Information [Line Items]    
Total Assets $ 57,499 $ 57,312
Investment in nonconsolidated affiliates 1,275 1,266
Segment Reporting, Reconciling Item, Corporate Nonsegment    
Segment Reporting Information [Line Items]    
Total Assets 5,333 5,180
Investment in nonconsolidated affiliates 45 42
Operating Segment Total    
Segment Reporting Information [Line Items]    
Total Assets 52,166 52,132
Investment in nonconsolidated affiliates 1,230 1,224
Packaging & Specialty Plastics [Member] | Operating Segments    
Segment Reporting Information [Line Items]    
Total Assets 28,966 29,034
Investment in nonconsolidated affiliates 740 711
Industrial Intermediates & Infrastructure [Member] | Operating Segments    
Segment Reporting Information [Line Items]    
Total Assets 11,830 11,928
Investment in nonconsolidated affiliates 348 367
Performance Materials & Coatings [Member] | Operating Segments    
Segment Reporting Information [Line Items]    
Total Assets 11,370 11,170
Investment in nonconsolidated affiliates $ 142 $ 146
v3.25.1
SEGMENTS AND GEOGRAPHIC REGIONS Significant Items (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Charges related to separation, distribution and tax matters agreements $ (98)  
Other Nonrecurring (Income) Expense (416) $ (91)
Gain (Loss) on Extinguishment of Debt (60)  
Segment Reporting, Reconciling Item, Corporate Nonsegment    
Segment Reporting Information [Line Items]    
Charges related to separation, distribution and tax matters agreements (98)  
Other Nonrecurring (Income) Expense (415) (46)
Gain (Loss) on Extinguishment of Debt (60)  
2023 Restructuring Program    
Segment Reporting Information [Line Items]    
Restructuring Charges (51) (91)
2023 Restructuring Program | Segment Reporting, Reconciling Item, Corporate Nonsegment    
Segment Reporting Information [Line Items]    
Restructuring Charges (50) (46)
2025 Program    
Segment Reporting Information [Line Items]    
Restructuring Charges (207)  
2025 Program | Segment Reporting, Reconciling Item, Corporate Nonsegment    
Segment Reporting Information [Line Items]    
Restructuring Charges (207)  
Operating Segment Total    
Segment Reporting Information [Line Items]    
Charges related to separation, distribution and tax matters agreements 0  
Other Nonrecurring (Income) Expense (1) (45)
Gain (Loss) on Extinguishment of Debt 0  
Operating Segment Total | 2023 Restructuring Program    
Segment Reporting Information [Line Items]    
Restructuring Charges (1) (45)
Operating Segment Total | 2025 Program    
Segment Reporting Information [Line Items]    
Restructuring Charges 0  
Packaging & Specialty Plastics [Member] | Operating Segments    
Segment Reporting Information [Line Items]    
Charges related to separation, distribution and tax matters agreements 0  
Other Nonrecurring (Income) Expense 0 (37)
Gain (Loss) on Extinguishment of Debt 0  
Packaging & Specialty Plastics [Member] | 2023 Restructuring Program | Operating Segments    
Segment Reporting Information [Line Items]    
Restructuring Charges 0 (37)
Packaging & Specialty Plastics [Member] | 2025 Program | Operating Segments    
Segment Reporting Information [Line Items]    
Restructuring Charges 0  
Industrial Intermediates & Infrastructure [Member] | Operating Segments    
Segment Reporting Information [Line Items]    
Charges related to separation, distribution and tax matters agreements 0  
Other Nonrecurring (Income) Expense (1) (8)
Gain (Loss) on Extinguishment of Debt 0  
Industrial Intermediates & Infrastructure [Member] | 2023 Restructuring Program | Operating Segments    
Segment Reporting Information [Line Items]    
Restructuring Charges (1) (8)
Industrial Intermediates & Infrastructure [Member] | 2025 Program | Operating Segments    
Segment Reporting Information [Line Items]    
Restructuring Charges 0  
Performance Materials & Coatings [Member] | Operating Segments    
Segment Reporting Information [Line Items]    
Charges related to separation, distribution and tax matters agreements 0  
Other Nonrecurring (Income) Expense 0 0
Gain (Loss) on Extinguishment of Debt 0  
Performance Materials & Coatings [Member] | 2023 Restructuring Program | Operating Segments    
Segment Reporting Information [Line Items]    
Restructuring Charges 0 $ 0
Performance Materials & Coatings [Member] | 2025 Program | Operating Segments    
Segment Reporting Information [Line Items]    
Restructuring Charges $ 0